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1. INTRODUCTION: THE ROLES OF METALS IN
BIOLOGY
From the perspective of a chemist, biology confers a rich variety
of roles on a number of metal ions. It is widely agreed that a
large fraction of the genomic output of living things contains
metal or metalloid ions, although estimates of this fraction vary
widely and depend upon which metal ions are considered.1−3
Moreover, recent reports suggest that, at least in some cases,
there are many uncharacterized metalloproteins.4 With
inclusion of the s-block metals such as Na, K, Mg, and Ca,
the proportion likely approaches 100%; recent estimates from
the protein data bank indicate that the prevalence of heavier
metal ions of atomic number above 20 within proteins is
around 22%,5 with Zn2+ proteins alone constituting about 11%.
Living organisms have an inherent and very rich physical
structure, with relevant length scales ranging from the
nanometer scale for subcellular structure to hundreds of
micrometers and above for tissue, organ, or organism-level
organization. The ability to derive the spatial distribution of
elements on this diversity of length scales is a key to
understanding their function.
Metals play essential and central roles in the most important
and chemically challenging processes required for life, with
active site structures and mechanisms that, at the time of their
discovery, have usually not yet been duplicated in the chemical
laboratory. Furthermore, diseases of metal dysregulation can
cause disruption in the distribution of metals.6 For example,
Menke’s disease and Occipital Horn Syndrome,7 and Wilson’s
disease,8 involve disruption in copper uptake and excretion,
respectively, through mutation in the ATP7A and ATP7B Cu
transporters.9 The mechanisms of action of toxic elements such
as mercury and arsenic are also of interest, as are essential
nonmetal trace elements, such as selenium. Likewise, an
increasing number of pharmaceuticals include metals or heavier
elements; such chemotherapeutic drugs include the platinum
derivatives cisplatin and carboplatin,10 some promising new
ruthenium drugs,11 and arsenic trioxide, which has been used to
treat promyelocytic leukemia.12 Understanding the localization,
speciation, and distribution of these at various length scales is of
significant interest.
A wide variety of heavier elements can be probed by X-ray
spectroscopic methods; these are shown graphically in Figure 1.
X-ray fluorescence imaging is a powerful technique that can be
Figure 1. Periodic table of the elements showing elements of biological interest that can be probed using X-ray fluorescence imaging. Elements are
divided into three categories, those that are physiologically important, those that are pharmacologically active, and those that are toxic or of
environmental concern. Those elements that can be detected using hard X-ray XFI are shown in bold color, while those that cannot are indicated by
a lighter shade of the same color. Some elements will fall into more than one category; for example, selenium is both essential and toxic in excess
with a relatively narrow margin separating adequate supply and the onset of toxic symptoms. Similarly, bromine is used pharmacologically but is also
a physiologically important element.
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used to determine elemental and chemical species distributions
at a range of spatial resolutions within samples of biological
tissues. Most modern applications require the use of
synchrotron radiation as a tunable and high spectral brightness
source of X-rays. The method uses a microfocused X-ray beam
to excite X-ray fluorescence from specific elements within a
sample. Because the method depends upon atomic physics, it is
highly specific and enables a wide range of chemical elements to
be investigated. A significant advantage over more conventional
methods is the ability to measure intact biological samples
without significant treatment with exogenous reagents. The
technique is capable of determining metal and nonmetal
distributions on a variety of length scales, with information on
chemical speciation also potentially available. Figure 2 shows
examples of rapid-scan X-ray fluorescence imaging at two
contrasting length scales: rapid-scan imaging13 of a section of a
human brain taken from an individual suffering from multiple
sclerosis and showing elemental profiles for Fe, Cu, and Zn;14
and a high-resolution image showing mercury and other
elements in a section of retina from a zebrafish larva treated
with methylmercury chloride.15 We will discuss both the state
of the art in terms of experimental methods and some recent
applications of the methods. This Review considers X-ray
fluorescence imaging with incident X-ray energies in the hard
X-ray regime, which we define as 2 keV and above. We review
technologies for producing microfocused X-ray beams and for
detecting X-ray fluorescence, as well as methods that confer
chemical selectivity or three-dimensional visualization. We
discuss applications in key areas with a view to providing
examples of how the technique can provide information on
biological systems. We also discuss synergy with other methods,
which have overlapping or complementary capabilities. Our
goal is to provide useful and pertinent information to
encourage and enable further use of this powerful method in
chemical and biochemical studies of living organisms.
Several acronyms are used for X-ray fluorescence imaging;
some commonly in use are X-ray fluorescence (XRF),
synchrotron X-ray fluorescence (SXRF), X-ray fluorescence
imaging (XFI), synchrotron X-ray fluorescence imaging
(SXFI), synchrotron radiation-induced X-ray emission
(SRIXE), rapid scan X-ray fluorescence (RSXRF), as well as
X-ray fluorescence microscopy and X-ray fluorescence mapping
(both of which are commonly abbreviated XFM). All of these
correspond to essentially the same experiment. Purists might
Figure 2. Examples of biological X-ray fluorescence imaging (XFI), illustrating the different accessible length-scales. Panel a shows a coronal section
of human brain taken post-mortem from an individual suffering from multiple sclerosis,14 with normalized levels of iron, zinc, and copper indicated
as shades of red, green, and blue. Panel b shows a thin section of larval zebrafish retina imaged at high resolution showing preferential accumulation
of mercury in the photoreceptor cells.15
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argue that most of what we discuss here is predominantly
mapping and not imaging; however, given that we will cover
both two-dimensional and three-dimensional applications, the
acronym used here is X-ray fluorescence imaging (XFI).
2. EXPERIMENTAL METHODS AND STRATEGIES
In essence, the technique of X-ray fluorescence imaging uses a
small or microfocused X-ray beam incident upon a sample, an
energy-dispersive detector to monitor the X-ray fluorescence,
and sample translation so that the X-ray beam sequentially
interrogates different parts of the sample to develop an image of
the sample. Essentially all modern applications of XFI in
biological systems employ synchrotron radiation as a high
spectral brightness source of X-rays. Synchrotron radiation
from a state-of-the-art third-generation source is of many orders
of magnitude greater spectral brightness than even the most
powerful rotating anode X-ray sources; the low concentrations
of metals in biological tissues mean that XFI is only practical on
these samples using synchrotron light. A detailed discussion of
the origins and properties of synchrotron light is outside the
scope of this Review, and has been reviewed by others.16 A
schematic of the experimental apparatus is shown in Figure 3.
Below we review different aspects of the experiment, with an
emphasis on those components that are likely to be selected or
adjustable by the experimenter.
2.1. Micro-Focus Optics
There are five important methods of generating a small or
microfocused X-ray beam: simple apertures, Kirkpatrick−Baez
(K−B) mirrors, capillary optics, Fresnel zone plates, and
compound refractive lenses. Excellent reviews of these methods
have been reported relatively recently,17−20 and therefore we
will discuss each method only briefly.
2.1.1. Apertures. The simplest method of generating small
X-ray beams, apertures, is most suitable when relatively large
beams are required. Because they do not focus X-rays, they are
often neglected in reviews, but much outstanding work has
been conducted using simple apertures. An aperture usually
consists of a precision slit assembly or a laser drilled aperture or
pinhole of fixed size (e.g., 20−100 μm), usually fabricated from
a high atomic number material such as tungsten or tantalum. In
general, it is good practice to locate the aperture close to the
Figure 3. Highly simplified and schematic plan view of the apparatus for conducting X-ray fluorescence imaging experiments. The X-ray source is
typically synchrotron light, used in conjunction with upstream X-ray optics (not shown) and in most cases an X-ray double crystal monochromator.
Figure 4. Schematic representation of a two-mirror Kirkpatrick−Baez system. The lines indicate the flight path of rays from the source to the sample.
The angle of incidence θ is shown on the first mirror. The two mirrors focus in orthogonal directions.
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sample, especially if upstream focusing optics are used, as
noncolinearity of the X-ray beams and scattering from the
edges of the aperture may result in different size projection,
sometimes called beam blow-up, at the sample. These effects,
especially the latter, can be reduced by means of a scatter slit or
second aperture downstream of the first.
2.1.2. Specular Optics. Two of the common methods of
X-ray microfocusing depend upon X-ray reflection: K−B
mirrors and capillary optics. Both require that the incident
angle θ between the optic surface and the incident X-rays is less
than the X-ray critical angle θc. Outside of the total external
reflection condition (i.e., θ > θc), the reflectivity of all materials
is negligible. The value of θc is dependent both upon the X-ray
energy and upon the atomic number and density of the material
used for the reflective optics. X-ray mirrors are often made of
silicon and coated with a material of high atomic number (such
as nickel, platinum, gold, or rhodium), as high atomic number
coatings give higher θc values, which for hard X-rays and
common coatings is generally between 0.1 and 10 mrad. An
alternative approach is to use multilayer mirrors. Here,
alternating layers of high and low refractive index materials
are used to achieve high reflectivity at angles greater than θc
through constructive interference at multiple surface interfaces.
2.1.3. Kirkpatrick−Baez (K−B) Mirrors. Probably the
most commonly used method of obtaining microfocused X-ray
beams are K−B mirrors.21 These comprise two spherical or
cylindrical mirrors in a crossed configuration21 with adjustable
bend radii to achieve optimum focus at different wavelengths. A
schematic diagram of a K−B pair is shown in Figure 4. In most
cases, the beam sizes achievable with K−B mirrors are of the
order of 1−5 μm, but in some cases sub-100 nm spot sizes have
been achieved.22 The focal length of most modern devices is
such that several centimeters are typically available between the
physical end of the optic and the sample. Recently, side-by-side
K−B mirror configurations, sometimes called Montel mirrors,
have been discussed.23,24 These provide a more compact system
that is capable of higher demagnification than traditional
sequential K−B mirrors, but at the time of writing they are not
in routine use.
Figure 5. Capillary microfocus optics. (a) Schematic diagram of a multiple-bounce tapered monocapillary microfocus optic. (b) The beam intensity
profile of a tapered metal capillary optic,26 measured using a cadmium tungstate scintillator placed at the focal point of the device.
Figure 6. Fresnel zone plate microfocus optics. (A) Simplified schematic diagram of a Fresnel zone plate microfocus optic. The X-rays from the
source are depicted as parallel rays, and following the zone plate converge on a focus at the sample. (B) Positioning of order sorting aperture and
beam stop in a typical Fresnel zone plate-based XFI experiment. The order sorting aperture serves to reject the light from diffraction orders other
than 1, with the sample ideally located at the order 1 beam focus.
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2.1.4. Capillary Optics. In most cases, capillary optics are
made of glass, although metal devices have been explored.
There are two basic types of capillary optics: polycapillaries and
monocapillaries. Both function by total external X-ray reflection
from the inner walls of the glass (Figure 5). Polycapillaries have
multiple small channels that guide X-rays by multiple internal
reflections along the channel’s inner wall, and focal spot sizes in
the range 10−50 μm are achievable.25 Polycapillaries have the
major advantage of being able to collect larger solid angles than
monocapillaries. Monocapillaries can be further divided into
condensing capillaries and single bounce ellipsoidal capillaries.
The latter focus the X-ray with a single reflection from its inner
surface with the advantage of superior efficiency. The focal
length of glass devices typically provides several millimeters
between the tip of the optic and the sample. Tapered metal
capillaries have been explored26 and used in a research
setting;27,28 these have the advantage of greater efficiency and
superior performance especially at low X-ray energies,29 and
can produce beams sizes of around 3−15 μm. The main
disadvantage of these devices is that the focal length is very
short, so that the sample needs to be located at about 0.1 mm
from the beam exit of the capillary. Polycapillaries fitted to
detectors have been used in the construction of confocal X-ray
fluorescence imaging systems, which we will discuss below
(section 2.7).
2.1.5. Compound Refractive Lenses. X-ray refractive
lenses, analogous to the glass lenses commonly used for visible
light, were considered impractical for many years due to the
weak relative refraction and strong absorption typical of X-rays.
However, lenses fabricated from low atomic number materials
such as Be, B, C, and Al have been used to minimize X-ray
attenuation due to absorption. Because of the low refractive
index, focusing refractive X-ray lenses must have a concave
shape. To achieve reasonable focal lengths, many individual
lenses can be stacked, forming a compound refractive lens and
yielding working distances of the order of 1 m. While they
remain a promising alternative, especially for high energy
applications,30 at the time of writing compound refractive
lenses are little used for microfocus optics in X-ray fluorescence
imaging applications, and we will not consider them further.
2.1.6. Fresnel Zone Plates. Effectively lenses for
monochromatic X-rays, Fresnel zone plates consist of a series
of concentric rings where the rings become narrower at larger
radii until the last and narrowest ring is reached (Figure 6). The
radii of the zone plate edges r are given by eq 1:





where n is the zone number, λ is the X-ray wavelength, and F is
the focal length. We consider here applications in which Fresnel
zone plates are used to focus a larger beam onto a small spot.
The focusing ability is based upon constructive interference of
the X-ray wavefront, modified by passage through the zone
plate, either in phase or more commonly by attenuation due to
the zones. In most cases, the working distance from the zone
plate to the sample is of the order of centimeters, and the spot
sizes achievable are defined by both the X-ray energy
(wavelength λ) and the outermost zone width Δr = rN −
Table 1. Comparison of Optics for Generating Micro-Beams for Hard X-ray XFIa
apertures Kirkpatrick−Baez mirrors capillaries Fresnel zone plates
max X-ray energy N/A 30 keV 20−40 keV 30 keV
typical resolution 50−100 μm 2−20 μm 1−20 μm 150−300 nm
best resolution ca. 20 μm 40 nm 1 μm 60 nm
focal length N/A several cm 0.1−5 mm several cm
disadvantages inefficient (low photon flux), poor resolution short focal length energy-dependent focal length
aOnly commonly used optics are considered; values given are those for an X-ray energy of 10 keV.
Figure 7. Physics of X-ray absorption and X-ray fluorescence. (A) Schematic diagram of the physics. The incident X-ray photon excites a core−
electron as a photoelectron creating a core hole in the process. This core hole is filled by dipole-allowed decay of an inner electron with concomitant
emission of an X-ray fluorescence photon. (B) Experimental X-ray emission spectra collected with incident X-ray energy above and below the
selenium K-absorption edge of a biological sample containing high levels of selenium. The spectrum with the incident X-ray energy below the Se K-
edge shows only scattered X-rays, whereas peaks due to the Se Kα and Se Kβ X-ray fluorescence are clearly visible when the incident X-ray energy is
above the Se K-edge.
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rN−1, where N is the number of zones. To avoid chromatic
blurring, N must be less than the inverse of the X-ray
wavelength resolution λ/Δλ. As with all grating optics, Fresnel
zone plates give different diffraction orders (Figure 6B), with
the higher orders having focal points that are closer to the optic,
zero order corresponding to a straight-through beam path, and
negative orders giving diverging beams. Only the first order
beam is used, and the other orders are predominantly rejected
by using an order-sorting aperture, which is placed between the
focus of the first-order beam (the location of the sample) and
the zone plate. Fresnel zone plates were first applied in soft X-
ray transmission microscopy31 for which spot sizes below 50
nm can be obtained. In the hard X-ray regime, beam spots of
the order of 100−300 nm can often be achieved. Fresnel zone
plates differ from the other commonly used micro focus optics
considered here (K−B mirrors and capillaries) in that their
focal length is dependent on the X-ray energy. This can cause
problems when performing μ-XAS experiments in which energy
is scanned (section 2.6) because ideally the sample should be
translated as a function of energy so as to maintain its position
at the X-ray focus; the alignment need only be slightly
imperfect for the beam to move across the sample during the
course of the μ-XAS scan. If the energy range being scanned in
μ-XAS is not large, then it may be better to maintain a
stationary sample position to avoid such problems.
The different methods used for generating microscopic X-ray
beams in XFI experiments are summarized and compared in
Table 1.
2.2. X-ray Fluorescence Detection
When the energy E of an X-ray is above an absorption edge of
an element, it can excite core electrons, creating a photo-
electron and a core hole. The core hole is rapidly filled by decay
of an outer electron with either the loss of an Auger electron or
the emission of an X-ray fluorescence photon. The division
between these two modes of decay is specified by the
fluorescence yield,32 and as it is the latter that concerns us
here we will not discuss electron yield further. Figure 7 shows a
simplified schematic diagram of the underlying physics together
with the fluorescence emission spectra of a selenium-containing
sample illuminated with X-rays above and below the Se K-edge.
The X-ray fluorescence emission lines of the elements occur
at characteristic energies, which are listed in the so-called
“orange book”, otherwise known as the X-ray data booklet.33
The specific X-ray fluorescence lines for K and L edges are
summarized in Figure 8. They obey the familiar dipole selection
rules common to most electronic spectra with Δl = ±1, where l
is the azimuthal quantum number. Thus, for a K-edge, the most
intense fluorescence lines are the Kα1 and Kα2, which arise from
the decay of 2p3/2 and 2p1/2 electrons, respectively, to fill the 1s
core hole. Similarly, the lines of secondary intensity, the Kβ1
and Kβ3, arise from decay of 3p3/2 and 3p1/2 electrons,
respectively. Because the K-edges of heavy elements such as
third row transition elements may be higher in energy than the
working range of most XFI beamlines, in these cases the L-
edges are used. Here, the most intense fluorescence lines arise
from decay of 3d electrons to fill the 2p hole; for example, for
LIII edges, the Lα1 and Lα2 arise from 3d5/2 → 2p3/2 and 3d3/2 →
2p3/2 transitions, respectively. Figure 9 shows a typical X-ray
fluorescence emission spectrum from a biological sample. In an
XFI experiment, conventionally the Kα1 and Kα2 lines cannot be
resolved by the detector (section 2.3) and are labeled as an
average Kα peak, likewise for the Kβ peak. All of the other, more
minor, lines from the K-shell elements can typically be
neglected (Figure 9). The Kα is almost always the fluorescence
line employed for experimental measurements because it is the
most intense; the Kβ may need to be taken into account in
cases where it overlaps with the fluorescence of another
element. For L-shell excitation with an energy above all three L-
edges, the primary fluorescence appears as a characteristic pair
of intense peaks, the Lα12 and the Lβ1, the most intense lines
from the LIII and LII edges, respectively. In principle, the X-ray
fluorescence lines from all elements in a sample with absorption
edge energies below that of the incident beam are observable,
but in practice experimental factors such as attenuation of lower
energy X-rays and low fluorescence yields for the lighter
elements mean that only fluorescence from elements heavier
than silicon is typically observable, unless the element is present
in great abundance. With biological samples the X-ray emission
spectrum is often dominated not by X-ray fluorescence but by
scattered X-rays. X-ray scattering can be divided into elastic or
Rayleigh scattering, and inelastic or Compton scattering. The
Figure 8. Origins and nomenclature of the major and minor X-ray fluorescence emission lines. The bold lines indicate the most intense fluorescence
transitions, with the boldest lines indicating those most suitable for X-ray fluorescence imaging experiments.
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former occurs at the same energy as the incident X-ray beam,
while the latter occurs at lower energies and shows a broad
asymmetric energy profile with a low-energy tail that can extend
into regions of the emission spectrum where X-ray fluorescence
of interest occurs (Figure 9). The Compton scattering energy
decreases as (1 − cos ϑ), where ϑ is the observation angle
relative to the incident beam, which creates challenges for
detectors that accept a large solid angle, such as array detectors.
To select for specific characteristic fluorescence lines, almost
all X-ray fluorescence imaging is achieved using solid-state
energy dispersive detectors, which allow the intensity of all
photons emanating from the sample to be plotted as a function
of the photon energy. Figure 10 shows the results of an X-ray
fluorescence imaging measurement on a biological sample, the
tip of a leaf from a selenium hyperaccumulating plant, showing
the levels of different elements in the sample together with the
fluorescence emission spectrum.
2.3. Solid-State Energy Dispersive X-ray Detectors
A variety of solid-state detectors34,35 are commercially available,
each with their advantages and disadvantages; we will discuss a
few different types. The properties sought are good efficiency
over a wide energy range, good energy resolution, and high
count rate capability. The literature on detectors tends to be
specialized, and at the time of writing we know of no reviews
that are readily accessible to researchers in chemistry or the life
sciences. We therefore briefly summarize below the different
types of detector currently available, their modes of operation,
and their advantages and drawbacks.
2.3.1. Germanium Detectors. The first of the commonly
used energy dispersive detectors that we will consider are the
Ge detectors (Figure 11). These essentially consist of large
reverse-bias diodes, typically arranged so that X-ray photons
enter through a thin ion-implanted p+ contact, with the n+
contact at the opposite end of the device (Figure 11). The
passage of an X-ray photon into the detector causes a cloud of
electron−hole pairs to form within the diode, the number of
which is proportional to the X-ray energy, assuming that the X-
ray photon and any scattered or fluorescent daughter photons
are all absorbed within the diode. The sweeping voltage causes
the electrons and holes, respectively, to drift toward the front
and the rear of the detector, giving a current pulse that is
proportional to the X-ray energy. Ge detectors give excellent
energy resolution and good efficiency at high X-ray energies,
Figure 9. Biological X-ray fluorescence emission spectrum. The
spectrum shown is that of a sample of human cerebral cortex from an
individual poisoned through skin exposure to dimethylmercury,
plotted with counts per second (CPS) on the ordinate. Two copies
of the trace are shown, one full-scale, and the other (labeled) with the
vertical scale expanded by a factor of 20. The spectrum was collected
using a Canberra LeGe detector using analog electronics with a
Gaussian shaping amplifier employing a shaping time of 2 μs. The
incident X-ray energy was 13 200 eV. Data were collected on SSRL 9-
3.
Figure 10. Example of elemental mapping using X-ray fluorescence imaging. The sample imaged is a leaf tip of the selenium hyperaccumulator
Astragalus bisulcatus, grown hydroponically with selenate-containing media. The X-ray emission spectrum is shown in the lower part of the figure,
with the Kα lines of different elements detected indicated. The Ar fluorescence arises from the air in the experiment. The optical micrograph is
shown in opt, plus XFI maps of Ca, Zn, and Se, together with a map for scattered X-rays. Ca can be seen to be concentrated in the leaf hairs
(trichomes), Zn in the spongy mesophyll cell layer within the leaf, and the Se is relatively uniformly distributed throughout the leaf. We note the
relative intensities of the lower and higher energy fluorescence lines, such as Ca and Se, do not reflect the absolute relative levels of these elements
because of air and window attenuation of the low-energy X-rays. Data were collected on SSRL 9-3, using a glass capillary microfocus optic, a silicon
drift (Vortex) detector, and a Gaussian shaping amplifier with a shaping time of 0.5 μs.
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although escape peaks can be problematic for incident X-ray
energies above the energy of the Ge K-edge [E(Ge K) = 11.1
keV]. Escape peaks arise from X-ray fluorescence from the Ge
of the detector itself; if these fluorescence photons are absorbed
by the detector, then there will be no effect, but if they “escape”
outside the detector, then the energy registered is that of the
incident photon displaced to lower energy by the Ge
fluorescence energy. The result is that for X-rays incident on
the detector with energy Ein > E(Ge K), there is a reproduction
of all structures above E(Ge K) displaced to lower energy by
the fluorescence energy (primarily the Kα), as illustrated in
Figure 12. The presence of escape peaks for incident energies
typical of XFI experiments can often obscure the fluorescence
lines of lighter elements in the sample; for example, in Figure
12 sulfur fluorescence would be difficult to observe because it
would be overlaid by the escape peaks. A small inconvenience
of Ge detectors is that they must be cooled to liquid nitrogen
temperatures. This is because at room temperature the thermal
excitation of the valence electrons can be sufficient to allow
them to cross the band gap and reach the conduction band. In
an appropriately cooled detector, the charge is transferred to a
field-effect transistor (FET) to convert the current into a
voltage as part of the preamplifier.
2.3.2. Lithium Drifted Silicon Detectors. Lithium drifted
silicon (SiLi) detectors are alternatives to germanium detectors
that do not suffer from problems due to escape peaks obscuring
low-energy fluorescence lines of interest. These devices also
require cooling with liquid nitrogen. They are less efficient at
high X-ray energies than the Ge detector, but more efficient
than the silicon drift detector, considered below, as the typical
diode thickness is 3−5 mm. In general, these devices are not
much used for modern XFI experiments as silicon drift
detectors are preferred.
2.3.3. Silicon Drift Detectors. Silicon drift detectors offer
many of the most desirable features, providing high count rate
ability with excellent energy resolution in a system that does
not require liquid nitrogen cooling. Reliable and relatively
affordable silicon drift detectors have now been available for a
number of years, and these systems are increasingly considered
the detector of choice in XFI experiments. Silicon drift
detectors have a concentric ring structure composed of p+
silicon implanted on one side of an n-type silicon chip. These
concentric rings are designed to generate an electric field
gradient across the device (Figure 13) with a small centrally
positioned contact that serves as the anode of the device. A
homogeneous p+ junction implanted on the reverse side of the
detector acts as an X-ray entrance window. As with other types
of solid-state detector, electron−hole pairs are generated by the
incoming X-ray photons, and these drift toward the anode
under the influence of the electric field. At the anode the charge
is transferred to the FET. Silicon drift detectors do require
cooling but not to the liquid nitrogen temperatures needed for
Ge detectors, and in the case of single detectors or small arrays
of discrete detectors, Peltier cooling is sufficient. Silicon drift
detectors do not suffer from escape peak problems because the
low energy silicon fluorescence photon is so readily absorbed
that it has negligible probability of escaping from the device.
Because the overall thickness of the device is usually of the
order of 450 μm, the efficiency at high X-ray energies is low,
Figure 11. Germanium detector. (a) Canberra LeGe germanium detector, and (b) a schematic diagram showing the basis of its function. The
beryllium window, the preamplifier, and the liquid nitrogen cryostat are indicated on (a).
Figure 12. X-ray fluorescence emission spectrum showing Ge detector
escape peaks. The data set is the same as that of Figure 9 but replotted
with a wider energy range to show the escape peaks, plotted with
counts per second (CPS) on the ordinate. X-rays impinging the
detector with energies above the Ge K-edge (indicated) generate
additional escape peaks due to loss of Ge X-ray fluorescence from the
detector. The escape peaks corresponding to both the Ge Kα and the
Kβ fluorescence lines are seen as echoes of the scatter peaks displaced
to low energy by the Ge Kα and Kβ fluorescence energies,
respectively. Data were collected on SSRL 9-3.
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which can be a major disadvantage of such devices. Thicker
devices that are more efficient at high X-ray energies have
recently been created by stacking individual silicon drift
detectors,36 and these are a promising new technology,
combining high count rate ability and excellent energy
resolution with no escape peak issues. We note in passing
that silicon drift detectors are also suitable for specialized
experiments such as low temperature X-ray magnetic circular
dichroism.37 This is because the Hall effect from the applied
magnetic field that will divert the current in a Ge detector will
not do so in a drift detector because in the latter case the
current flow is transverse to the detector axis.
2.3.4. Solid-State Detector Data Readout and Pre-
processing. The data from a solid-state detector are typically
processed by analog electronics or by a digital equivalent. With
both analog and digital systems, a charge preamplifier with an
FET generates a pulse train that feeds the subsequent
processing electronics. The preamplifier is generally an integral
part of the detector and is not normally adjusted by the user.
With analog electronics, the preamplifier pulse train is fed to a
shaping amplifier, operating with user-selected shaping time
(see discussion in Detector Dead Time Effects), which in turn
is used to feed either a set of single channel analyzers adjusted
to discriminate voltages corresponding to the fluorescence lines
of interest or an analog-to-digital converter (ADC), which
would be used to record the whole fluorescence emission
spectrum. With the digital alternative, the preamplifier pulse
train is fed to a digital signal processing unit containing a high-
speed ADC and firmware that analyzes the shape of the pulse
train to effectively give the entire fluorescence emission
Figure 13. Silicon drift detector. Part (a) shows a SII Vortex 4-element array detector, with the beryllium windows for the four detectors seen on the
right side of the photograph, part (b) shows a schematic diagram of a single silicon drift detector element showing the surface of the detector with
the drift rings, and part (c) shows a side-on view of a single silicon drift detector element with the current flow indicated.
Figure 14. Schematic diagram of energy dispersive solid-state detector signal processing. The preamplifier pulse train shows sharp step-like voltage
increases corresponding to the arrival of photons at the detector, superimposed upon a slower exponential decay. The size of the preamplifier voltage
steps is proportional to the energy of the photons. The preamplifier pulse train can then be analyzed either by older analog electronics, using a
shaping amplifier (a typical oscilloscope type display is depicted, triggering on the voltage rise), the output of which is sent to an analog to digital
converter, or directly by modern digital signal processing. The latter involves a fast analog to digital converter, and real-time shape analysis of the
preamplifier pulse train.
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spectrum. The function of processing electronics is summarized
in a simplified schematic manner in Figure 14.
With an analog system, the output of the shaping amplifier
can be passed to an ADC and to a multichannel analyzer
(MCA) in which pulses of different voltages are accumulated as
a histogram of the emission spectrum of the samples, which is
commonly referred to as the MCA spectrum. If a sufficiently
fast ADC is available, then the entire MCA spectrum can be
recorded to computer for each data point. Alternatively, a
number of single channel analyzers (SCAs) can be used to
register shaping amplifier pulses within voltage ranges
corresponding to fluorescence lines of interest. The MCA is,
in any case, useful to determine the SCA voltage limits, and is
often used in conjunction with a delay amplifier and coincident
and anticoincident gating of the ADC to visualize this process,
which is commonly called windowing.
In general, the digital systems have the significant advantage
of providing the complete emission spectrum (or MCA
spectrum) much more readily than the analog systems. In the
recent past, analog systems could still operate at higher count
rates for a given energy resolution than the digital alternative,
but recently the gap between the digital and analog systems has
closed as the digital systems have increased in speed. The Maia
array detector38−40 is discussed below (in Array Detectors), but
we will briefly consider the electronics of this system here. This
large array detector system has very impressive performance
with real-time low-latency pulse processing employing high-
density application-specific integrated circuits. The data
processing pipeline is implemented using a large field
programmable gate array (FPGA) processing subsystem
employing fine-grained parallelism.39,40 Another advantage of
the new digital systems is also exemplified by the Maia
electronics, which is the compact nature of the hardware. Thus,
analog electronics for Maia would require close to 10 full height
racks, with considerable quantities of cable while the Maia
digital processing system is attached to the detector, with an
overall system size of only 140 × 310 × 42 mm3.39,40 Some of
the newer commercial digital processing systems such as the
Xspress 3 system from Quantum Detectors (Harwell, Oxford,
UK) or the Falcon X (XIA, Hayward, CA) can now easily
exceed analog systems in performance. At the time of writing,
and in most cases, the optimum readout electronics for XFI are
considered to be the digital option.
2.3.5. Detector Dead Time Effects. All solid-state
detectors suffer from electronic dead time effects. If the time
taken to process a photon is τ, the detector will not register the
arrival of another photon within τ. Moreover, the dead time is
extended by a further τ following the arrival of the second
photon. This gives rise to what is known as a paralyzing or
extending dead time,34,41 for which the measured count rate r is
related to the incident count rate ρ by
ρ= ρ τ τ− ̅−r E E( ) ( ) e E E( )[ ( )] (2)
where τ ̅ is the average value of τ over the entire spectrum. The
effects of electronic dead time are illustrated in Figure 15. While
dead time correction is often possible,42 it is generally
considered desirable to operate solid-state detectors at count
rates that are sufficiently low that the exponential term
approximates to unity, in what is called the pseudolinear
regime. In general, there is a trade-off between dead time effects
and energy resolution. At shorter pulse shaping times (or the
digital equivalent, often called the peaking time), the detector
will be able to operate faster (at higher count-rates) but with a
poorer energy resolution. With longer shaping times, the
detector resolution can approach the theoretical optimum as
discussed below, but in this case count rates are limited.
2.3.6. Pile-Up. Pile-up events occur when pulses originating
from two photons arrive closer in time than the pulse
resolution of the system.34 There are two types of pile-up
that are of interest in XFI detection. The first, more common
type of pile-up, is where the second pulse arrives on the tail of
the first, potentially resulting in incorrect pulse amplitude
determination and broadening or distorting the energy peak in
the output spectrum. The second type of pile-up happens when
photons arrive sufficiently close in time that the two pulses
appear as a single pulse with amplitude the sum of the two
individual amplitudes. This is registered just as if it were arising
from a single photon with the sum of the energy of the two
photons, and gives rise to an apparent high energy peak called a
pile-up peak. The process by which pile-up events are
discriminated is called pile-up rejection or detection, and a
variety of electronic34 and digital43 means are employed. In
most cases, these methods are sufficiently effective that users of
modern spectrometer systems do not need to be concerned
about their effects. With analog detector electronics, pile-up
events are rejected with loss of signal, but modern digital signal
processing electronics can in principle provide effective
estimation of nearly overlapping pulses resulting in fewer
rejected events.
2.3.7. Energy Resolution. As discussed above, the energy
resolution of a solid-state detector is a function of the selected
operating conditions. Under conditions where dead time effects
are not prevalent, the measured peak shape is usually best
approximated as a Gaussian, with detector energy resolution
usually expressed as a full width at half-maximum (fwhm) or
half-width at half-maximum (hwhm), relating to the width of
the peak at half of the maximal measured intensity. The energy
resolution is a function of the amplifier pulse shaping time or
the digital peaking time (which are essentially functionally
equivalent but numerically different), the operating count-rate,
and the level of detector saturation (dead time). Because the
use of a short shaping time will not include all of the
preamplifier pulse, and the use of a very long shaping time will
include too much signal noise, careful matching of the
preamplifier output is required to obtain optimum resolution.
For a well-optimized detector system such as a modern
germanium or silicon drift detector, operating at around 10
keV, an energy resolution close to the theoretical best possible
Figure 15. Solid-state detector electronic dead time effects. The
detector employed for the measurements was a Canberra LeGe with a
spectroscopy amplifier Gaussian shaping time of 0.125 μs. The sample
was 1 wt % cupric oxide in a polyvinylpolypyrrolidone pressed disk
with incident count rates adjusted by driving a slit blade through the
beam incident on the sample. Data were collected on SSRL 2-3.
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resolution of about 150 eV fwhm should be achievable at count
rates with negligible dead time. Thus, for the Ge detector
example shown in Figure 9, a relatively long amplifier shaping
time of 2 μs was used with count rates limited to nonsaturating
values, resulting in an energy resolution of about 160 eV fwhm.
In most cases, however, the selected amplifier shaping times
will be shorter to allow collection of high count-rate data. Thus,
a 0.125 μs shaping time will allow high count rates (Figure 15)
with energy resolutions in the range of 350−400 eV fwhm and
count-rates in the vicinity of 100 000 counts per second. An
intermediate example is shown in Figure 10, in which a 0.5 μs
shaping time provides an energy resolution of 200 eV fwhm
with a silicon drift detector. Using the most modern digital
signal processing hardware, considerably better energy
resolution at high count-rates is possible, with little degradation
in resolution even at the highest count rates.
2.3.8. Array Detectors. One solution to the dead time
problem of limited count rates is the use of array detectors.42 A
number of individual detectors are combined, each with similar
(ideally) independent electronic dead time to multiply both the
overall count rate and the solid angle of fluorescence detected
by the number of detectors within the array. Arrays can be
composed of monolithic devices or arrays of discrete detectors
packed into a single housing. In general, the larger arrays are
found on beamlines dedicated to X-ray absorption spectrosco-
py, as these have larger X-ray beam sizes and can typically
provide much greater photon fluxes at the sample, leading to
correspondingly greater detector dead time problems. Never-
theless, it is common to find small arrays such as the four-
element silicon drift detector array Vortex-ME4 (Hitachi High-
Technology Science America, Inc., Northridge, CA), which has
an active area of 170 mm2. Monolithic detectors are also
available, typically germanium devices, which can accept good
solid angles with little dead area between the pixels. The Maia
detector38−40 is a sizable monolithic array that is currently in
use at the X-ray fluorescence microscopy beamline at the
Australian Synchrotron and most recently at the Cornell High
Energy Synchrotron Source. The system consists of a 20 × 20
pixel silicon monolith detector, with the middle square of 4 × 4
pixels removed to make a central hole, yielding 384 potentially
active pixels in the monolithic array. The illuminating X-ray
beam is projected through the central hole and onto the
sample, which must be about 10 mm away. The chief advantage
of this geometry is that the detector accepts more solid angle,
and the chief disadvantage is that it must also accept substantial
scattered radiation. Siddons et al.40 have pointed out that this is
not overwhelming, but can be useful in providing an estimate of
sample density. Because each pixel is 1 × 1 mm2, the system
accepts a very large solid angle and has an integrated pipelined,
parallel processor with embedded data analysis. The individual
array pixels have a maximum count rate of about 30 000 counts
per second, and the resolution is worse than competing
systems, requiring sophisticated data analysis methods; never-
theless, the system is very impressive, with high sensitivity and
rapid scan ability.
2.3.9. Other Detector Systems. Although what follows
does not relate to solid-state detectors, we briefly discuss them
here as they present alternative strategies that may have
applications for specific systems. Considerably higher energy
resolutions are available through the use of crystal optics, with
commercial detectors including a log-spiral bent Laue
detector,44 available from FMB Oxford, UK. These systems
use crystal optics to provide high energy resolution for
fluorescence in a narrow range, and must be used with another
detector (e.g., a nondispersive detector) employed to register
the X-rays. The major advantage of these systems is improved
discrimination of nearby fluorescence lines and superior
background rejection, both of which arise from the high energy
resolution. Moreover, in principle there are no inherent count-
rate limitations due to detector dead time effects. The
disadvantage is that fluorescence from only one element at a
time is registered, and while these systems could be used in
combination with a solid-state detector, they will likely be
restricted to niche applications. Similar arguments apply to
commercial crystal-based electron microscopy wavelength
dispersive detectors (e.g., Oxford FMB INCAWave spectrom-
eters) that can be found on a number of beamlines capable of
XFI measurements. These systems typically have a variety of
different crystals and use a Johannson geometry Rowland circle
affording excellent energy resolution, corresponding to about
30 eV fwhm, but probing a low solid angle.
2.4. Sample Scanning Systems and Experimental
Strategies
With synchrotron light sources the X-ray beams are static, and
the sample must be moved relative to the incident light. The
stage system selected will depend upon the required spatial
resolution and speed of movement, and can include several
types. Stepper motor driven stages can have a large range of
travel, be scanned reasonably rapidly, and move with a typical
precision of the order of 1 μm. So-called DC-servo stages
combine a direct current motor plus gear reducer to a coupled
position sensor in a closed feedback loop. They have the
advantage of being able to move very rapidly and precisely and
have excellent ranges. Piezoelectric stages are capable of the
most precise movement, depending upon deformation of
piezoelectric materials under the influence of an applied electric
field; their main disadvantage is that the range of motion is
typically quite small.
Irrespective of the type of stage used, two different types of
data collection strategy are employed in modern systems:
point-by-point and continuous or fly scan. With the point-by-
point data acquisition strategy, the sample is moved to a
location, and, possibly following a settling time, the data are
acquired on a stationary sample. The time taken to scan
samples with this strategy is often considerable; for example, a
typical midscale resolution X-ray fluorescence mapping data set
might be 250 pixels ×250 pixels, with a collection time of 0.2 s
per point, with an additional 0.1 s per point required to move
the stage and perhaps allow for settling. A single energy image
collected in this way would take more than 5 h. Continuous
scan is a much faster strategy; here, the sample is moved
continuously with data being collected while the sample is in
motion. The simplest such strategy is to scan the sample in one
direction and then rapidly return to the start of the next raster,
but more efficient still is a bidirectional mode in which left-to-
right and right-to-left raster scans are interlaced. Effective dwell
times can be reduced to the milliseconds range, and a scan that
would take many hours in point-by-point mode can be rapidly
completed in a fraction of the time, albeit with reduced signal-
to-noise corresponding to shorter effective count times.
Continuous scan mode leads to some inevitable motion
blurring of the detail in the image, and is most effective for
samples in which signal counts are not statistically limited by
dilution of the elements of interest. In dilute cases, the point-
by-point mode may be the most effective because accumulation
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of sufficient counts for the fluorescence signal of interest can
require averaging. Point-by-point also potentially yields the best
spatial resolution as no motion blurring should be present. Very
large samples can be imaged using continuous scanning, with
examples including paintings,45 ancient manuscripts,46 and
large fossils.47,48
In some experiments, individual images of samples at a
number of different X-ray excitation energies are used to
determine chemical information. This method is discussed
below in section 2.6. In this case, we effectively scan in three
dimensions, one being the X-ray energy and the other two
orthogonal axes of sample motion. In many XFI setups, the X-
ray monochromator will take considerably longer to complete
an energy move than the sample stage does to move between
pixels. In this case, the most effective scanning method is
generally to scan an individual raster at successive X-ray
energies, and then go to the next raster on completion of the
sequence of energies.29 This method, summarized in Figure 16,
minimizes the time difference between energies, and allows
accumulation of a complete fractional map at all energies in
case of equipment or software failure or sample deterioration
during the experiment.
During oversampling, the sample is scanned with a step-size
that is finer than the beam-size, which can yield a small amount
of additional detail when compared to using a step-size that is
the same as or coarser than the beam-size. The beam-size is
usually expressed as a full-width half-maximum, determined by
scanning a wire or slit blade across the beam, and can be
thought of as having a distorted Gaussian-type profile (e.g.,
Figure 5), sometimes broadened in one dimension. Assuming a
Gaussian beam profile, sharp features within an image that are
spatially separated by the full-width half-maximum of the beam
spot should in principal be resolvable by using oversampling.
2.4.1. Sample Geometry. The geometry of an exper-
imental setup is also an important factor. The two common
sample geometries relate to the angle of the surface of a flat
sample with respect to the incident beam. Probably the most
common is the 45° geometry (Figure 17) in which the sample
is inclined at 45° to the incident X-ray beam. The fluorescence
detector is oriented at 90° to the incident beam in the
horizontal plane, at which angle the X-ray scatter is minimized,
allowing a degree of background suppression while minimizing
detector saturation. The disadvantage of this geometry is that
the non-normal incident X-ray beam is spread out horizontally
on the sample by a factor of 21/2 with potential parallax
problems. In addition, for imperfectly flat samples, more
prominent “edge effects” may result in which physical edges are
either preferentially illuminated or cast into shadow, depending
upon the orientation with respect to the beam. An alternative
geometry is normal incidence in which the sample is oriented at
90° to the incident beam (Figure 17). This has the advantages
of being conceptually simpler with optimal horizontal beam
size. Edge artifacts and parallax problems may be less
prominent, but may still be present as the detector will be at
an angle relative to the sample. The major disadvantage of this
Figure 16. Sample scanning strategy for a multienergy image. Individual rasters are scanned at each energy, building up a complete multienergy map
with as little time separation between the individual rasters as possible. In the example, four energies (E1−E4) are in the process of being recorded,
with the active raster at E3.
Figure 17. Plan view schematic diagrams of different sample
geometries for X-ray fluorescence imaging. The geometry shown in
(a) has the plane of the sample oriented at 45° to the incident beam,
while that shown in (b) has the sample plane oriented at normal
incidence to the illuminating X-ray beam.
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geometry is that the detector is usually positioned at an angle to
the beam at which more scattered X-rays are sampled and the
Compton scatter is shifted to lower energy. In some cases, the
choice of setup geometry is constrained by the experiment or
physical limitations of the equipment, such as with the Maia
detector, which is designed to be used only at normal incidence.
Each of these experimental configurations has its own
advantages and limitations, and ideally the experimenter should
be able to choose between them. However, changing
configurations is not always convenient and can consume
precious beamtime from the assigned allotment so that
experimenters are not often presented with this choice.
2.4.2. Microscope. Another component common to nearly
all XFI experiments is an optical microscope (Figure 3, Figure
17). This is used to check alignment of samples with respect to
the beam prior to scanning the sample, and some experimental
setups have more than one microscope, each suited to a
particular experimental aspect. In the 90° orientation (Figure
17), a microscope downstream of the sample can be used, but
care must be taken that X-rays do not strike the lens both
because commercial optical glass contains many elements of
interest (e.g., high levels of zinc) and because the X-rays will
damage the lens by induction of color centers. In some cases, a
mirrored pellicle made of a low X-ray cross-section material
(such as silicon with a thin aluminum coating on one side) can
be used to obtain a straight-on view of the front of the sample
with no parallax errors (Figure 17). At many beamlines, the
sample is fiducialized at an off-line microscope before the
sample is brought to the beamline; this enables the regions of
interest to be chosen ahead of time.
2.5. Quantitative Analysis of Two-Dimensional Images
Quantitative two-dimensional maps of flat samples such as
tissue sections are often shown in terms of what is sometimes
called areal density, typically with the somewhat unorthodox
units of μg/cm2, representing the total amount of an element of
interest (in μg) within the sample expressed as a function of
surface area, and neglecting thickness. Calibration of the raw X-
ray fluorescence data to quantitative units of this type is done
by using measurements of standards of known composition and
relating the measured fluorescence peak areas to the peak areas
of the standard. Quantification of fluorescence data is often
done by simple binning of counts, within an electronic window,
as shown in Figure 10. This may be done if the fluorescence
emission spectrum is not available digitally; for example, if the
beamline employs only analog electronics, then single channel
analyzers can be used to discriminate amplifier pulses within a
specific voltage range. In many cases, this binning method can
produce reasonably accurate results, although if the energy
dispersive data are available, then a peak-fitting approach is
usually more accurate.
Well-established methods for peak-fitting are available with
sophisticated background corrections;49 these approaches have
major advantages over binning if partly overlapping fluo-
rescence peaks are present in the spectrum. In many cases, the
distribution in intensities of peaks (e.g., Figure 9) is sufficiently
broad that the results are best displayed on a logarithmic scale.
Figure 18 shows an example of peak fitting and illustrates the
potential benefits of this method. For the case of dilute samples
in which the fluorescence energy of primary interest is
reasonably close in energy to the incident X-ray energy, the
low-energy tail of the inelastic scattering peak can provide a
substantial background. This occurs, for example, in measuring
selenium in tissue samples using an energy just below the
bromine K-edge (e.g., 13 450 eV) (see section 2.13). In such
cases, and when a full energy dispersive spectrum is not
available on a per-pixel basis, adequate background removal can
be achieved by careful measurement of both scatter and
fluorescence signal and estimating and subtracting the over-
lap.50 In some cases, standards are available that contain known
quantities of the element or elements of interest, but in other
cases elements with nearby fluorescence lines have been used.
In the quantification of Hg, for example, certified standards for
gold and thallium, the elements adjacent to Hg in the periodic
table, were used because standards containing elemental
mercury showed a gradual decrease in signal over time,
presumably due to loss of elemental mercury vapor.51 In the
case of very thin samples, such as tissue sections, which may be
0.2−10 μm thick, there is usually no need for correction for
thickness in the hard X-ray regime. In the case of thicker
samples, such as whole small organisms, a correction for
thickness should be applied. Correcting for thickness is simple
in principle, and depends upon the X-ray attenuation by both
sample and experiment (e.g., by windows, flight paths, etc.) of
incident and fluorescent X-rays. For an X-ray beam penetrating
into a sample of depth t, with incident X-ray intensity I0, the X-
ray intensity at t is I, given by
= μ−I I e t0 (3)
where μ is known as the X-ray absorption coefficient.
Neglecting the effects of absorption edges, μ varies with X-
ray energy E approximately as 1/E3, or more specifically for an
element μ ≈ ρZ4/ME3, where ρ is density, Z is the atomic
number, and M is the atomic mass. The X-ray absorption
coefficient is the product of the X-ray cross-section σ and the
density ρ and is related to the absorbance A by










McMaster has tabulated the X-ray cross-section for most of the
periodic table, from atomic number Z = 1 to 94, with only a
Figure 18. Example of quantification of X-ray fluorescence data using
peak fitting. The data used in this example are those shown in Figure
9; here, the points represent experimental data, while the continuous
(black) line shows the best fit. Selected individual fluorescence
contributions are shown as filled colored areas. Partly overlapping
fluorescence lines such as the Zn Kβ and Hg Lα (indicated in the
figure) would be difficult to properly quantify without peak-fitting,
especially under lower energy resolution−higher count rate conditions.
The elastic scatter, inelastic scatter, and background contributions to
the fit are not shown, and some of the lower intensity fluorescence
peaks are below the bottom of the plot due to the log scale.
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handful of exceptions, all of which are heavy elements (i.e., Z =
84, 85, 87, 88, 89, 91, and 93).52 For an X-ray fluorescence
imaging experiment, the attenuation of both the incident X-ray
beam at energy E and the fluorescent X-ray beam at energy Ef
should be considered.
Pickering et al.50 have described a simple method that can be
used for samples of irregular thickness, such as plant tissues.
This uses the measured transmittance of the sample and
assumes that the absorption of the plant material can be
approximated as water (i.e., using σ and ρ for water). Thus, if Ae
is the experimentally measured absorbance, and A and Ab are
the absorbances of the sample and the background (from X-ray
windows, flight paths, etc.), respectively, then the sample
absorbance can be obtained by the difference A = Ae − Ab =
σρt, and the sample thickness t easily be obtained as
= − σρt A A( )/e b (5)
In many biological cases, approximating the sample as being
composed essentially of water is either an excellent
approximation, or the materials present are composed of
other abundant light elements (C, N, O, H) in which case they
will have X-ray absorption characteristics similar to those of
water. Calculation of molar quantities and concentrations from
the areal densities and the per-pixel sample thickness t is then a
relatively simple matter.
Even with a constant incident X-ray energy E, different
elements will have different fluorescence energies Ef, and for
each of these the penetration depth and signal at the detector
will be different. For a planar sample inclined at an angle θ to
an incident X-ray beam of intensity I0 with a detector at an
angle φ to the plane of the sample, in the limit of a small solid
angle β accepted by the detector, and neglecting absorption by
X-ray windows, atmosphere, etc., then the fluorescence F from










where ω is the fluorescence yield, and α incorporates the X-ray
absorption coefficients at the incident X-ray energy μi and at













The sample thickness tf required to obtain a fraction f of the
maximum possible signal (that obtained with an infinitely thick







Figure 19a and b shows a series of fluorescence curves for a
selection of biologically relevant elements plotted as a function
of sample thickness t, calculated using eq 6 assuming a water
matrix and a 45° geometry (Figure 17a; θ = φ = 45°). Figure
19c shows curves of tf against atomic number Z for the K-edge
fluorescence of midrange elements, showing that for lighter
elements the surface produces most of the signal. Thus, for
sulfur and selenium, in a dilute aqueous sample, 90% of the
maximum possible signal will come from the first 40 μm and
the first 3 mm, respectively.
In an elegant application of quantitative methodology, De
Samber et al.53 have used the differential attenuation of the
calcium Kα12 and Kβ13 fluorescence lines to correct three-
dimensional data collected using confocal XFI (section 2.7) of
the small freshwater crustacean Daphnia magna. These workers
exploited the rapidly changing X-ray cross-section in the
vicinity of the calcium fluorescence energy (the Kα12 and Kβ13
are at 3690.5 and 4012.7 eV, respectively33) plus the intensity
ratio of the measured intensities F Kα12 and Kβ13 to estimate the
X-ray attenuation of the fluorescence for all elements in the
sample. They define the ratio R = FKα12/FKβ13, which holds a
value R0 without any attenuation, and which is expected to be
11.54 for a K-edge,33 and a parameter k, which is defined as the
ratio of the fluorescence energies k = EKα12/EKβ13. For an effective
depth from which the signal originates d, De Samber et al. give










These workers use this relationship to estimate that, for their
samples, the Ca Kα12 signal is attenuated to about 17% and the
Zn Kα12 signal to about 87%.
53
Figure 19. Fluorescence signal depth attenuation. Curves are
calculated for selected biologically relevant elements, but omitting
the solid angle term (β/4π) in eq 6; (a) shows the fluorescence signal
without accounting for fluorescence yield ω,32 and (b) shows the same
data including fluorescence yield but on a logarithmic scale. Curves of
the required thickness tf for 10% increments between 90% and 10% of
the maximum possible signal are shown in (c) plotted against the
atomic number Z of the fluorescing element (eq 8). In all cases, the
absorption was approximated by that of water, with an incident X-ray
energy of 13 450 eV, and both θ and φ set to 45°.
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Recently, a novel approach to quantification has been
reported by Kosior et al.54 These workers used magnified
phase-contrast imaging to provide an indication of projected
mass for lyophilized cells. This information was used in
combination with XFI to provide quantitative estimates of
subcellular concentration for a variety of trace elements.54
2.6. Chemically Selective Spectroscopic Imaging
Chemically selective XFI is an extension of the X-ray
fluorescence microprobe method that exploits the chemically
sensitive differences in X-ray absorption near-edge spectra to
generate images or maps of specific chemical types.50 The
method was first suggested and tested for transmittance-based
imaging in a basic form by Kinney and co-workers,55,56 but
more than a decade passed before the first real application using
X-ray fluorescence.50 The methods rely on the chemical
sensitivity of near-edge spectra. Near-edge spectra, sometimes
called the X-ray absorption near-edge structure (or XANES),
are often rich in structure,5 which arises from X-ray excited
transitions of the core electron to unoccupied levels near to the
valence levels. Intense features are usually electric dipole
allowed (Δl = ±1), although weak features due to electric
quadrupole transitions can also be observed,57,58 and can be
used as fingerprints of overall chemical type by simple
comparison with spectra of standard compounds. In the case
of transmittance measurements, such as scanning transmission
X-ray microscopy (STXM), the signal is sufficiently strong that
very short dwell times can facilitate a data set, which comprises
an image at every energy point in the near-edge spectrum, from
which can be derived a near-edge spectrum at every pixel.
With X-ray fluorescence on dilute biological levels of metals,
longer count times mean that usually such a complete data set
cannot be collected in a tractable amount of time. Two basic
methods can be used to derive similar information. The first is
micro-X-ray absorption spectroscopy (μ-XAS), in which a
conventional fluorescence image is taken, and then the sample
is moved to locate the microfocused X-ray beam on selected
points of interest and a spectrum recorded. In μ-XAS the
extended X-ray absorption fine structure (EXAFS) portion of
the spectrum can also be examined, provided that signal-to-
noise and tolerance to radiation damage are sufficient, to give
local structural information.5 Figure 20 shows an example of μ-
XAS combined with an elemental image using an incident X-ray
energy well above the absorption edge of the elements of
interest in the sample. The spectra show that different chemical
forms are present in different locations. There are two major
disadvantages to this method. First, only a small number of
specific locations can be interrogated by recording the μ-XAS,
which gives rise to the possibility of missed detail, and second
that the X-ray radiation dose to the sample is considerable
because of the longer duration required to scan the μ-XAS
spectra. This in turn increases the risks of radiation damage
with significant chemical change to the sample (section 2.11).59
The second method of chemically selective imaging requires
collection of multiple images at different energies. As we have
discussed above, elemental imaging normally employs an
incident X-ray energy that is well above the absorption edges
of the elements to be studied. Chemically selective X-ray
fluorescence imaging uses multiple incident energies across the
absorption edge of the element of interest. The method exploits
the aforementioned sensitivity of near-edge spectra to chemical
species with incident X-ray energies carefully chosen to confer
chemical selectivity. It requires prior near-edge analysis or some
knowledge of the probable composition of the system so that
appropriate energies can be chosen; typically X-ray absorption
spectroscopy is carried out first on a bulk sample to establish
candidate energies. When using an energy-dispersive detector
with good background rejection, the number of necessary
incident energies is minimally equal to the number of species to
be mapped.50 For energies E and i components, we can write an
expression for the fluorescence, F(E).




where ks is a quantification constant of proportionality derived
from measurements of standards of known concentration, mi is
the molar quantity of component i per pixel, and Ii(E) is the
normalized intensity of component i at energy E, derived from
measured spectra.50 This equation can be solved for the molar
quantities mi. As an example we consider this method for the
fern Pteris vittata.28 This plant, the Chinese brake fern, can take
up arsenic from the soil in the form of the oxy-anion arsenate (a
mixture of [H2AsO4]
− and [HAsO4]
2− at neutral pH), which is
relatively nontoxic, but then transforms it into the much more
toxic oxy-anion arsenite (essentially 100% [As(OH)3] at neutral
pH) and hyperaccumulates it in its tissues.28,60,61 Figure 21a
shows spectra of aqueous solutions of arsenite and arsenate at
physiological pH, and the X-ray fluorescence imaging data at
two incident X-ray energies (E1 and E2 in Figure 21) together
with the transmittance data. The transmittance is essentially
Figure 20. Example μ-XAS experiment on selenium in a red lentil seed
(Lens culinaris). The central image shows the X-ray microprobe results
with Ca, Se, and Zn, indicated as red, green, and blue, respectively.
Selected locations on the image, as indicated, were then interrogated
by using μ-XAS, with the different spectra indicating the presence of
chemical differences between the different parts of the lentil seed. Data
were collected on SSRL 9-3 using a glass monocapillary with a 6 μm
exit (focal length 2 mm).
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invariant between the two energies because the bulk of the X-
ray absorbance is not specific to the relatively dilute arsenic but
from the other components of the tissue. The bulk of the
arsenic present is stored in the tissues as arsenite and as a result
the total fluorescence at the two energies looks very similar, but
solving eq 5 gives images that clearly show the arsenate to be
present at very low levels in the tissues and additionally to be
confined to transport vessels seen as faint lines in the center of
the leaf (Figure 21).
Since the first report of the methods for quantitative
analysis,50 chemically specific fluorescence imaging has been
employed to follow chemical localizations of trace elements in a
number of biological and environmental systems.26,50,62 Other
workers have reported attempts at contrast resolution by
measuring total quantities of an element with incident X-ray
energies above and at a near-edge peak of one component, but
in these cases quantitative analysis was lacking.63−65 In some
systems, energy dispersive fluorescence detection is not as
useful because of the relatively small separation between scatter
and fluorescence. For example, at the lower energies of the
sulfur K-edge, the separation between elastic scatter and S Kα
fluorescence is almost an order of magnitude smaller than with
the hard X-ray case, being only about 160 eV, which is
sufficiently small that the fluorescence and scatter cannot be
adequately resolved by conventional solid-state dispersive
detectors.29 In this case, a slightly more complex approach
can be used in which additional images at incident X-ray
energies above and below the absorption edge of the element of
interest are collected. We note that even though discrete
fluorescence peaks may not be readily resolved, there is still
important additional information from dispersive detection
systems, including the fluorescence of elements of lower atomic
numbers, such as phosphorus. We can assume that the total
measured signal T(E) at incident X-ray energy E can be
expressed as the sum of two components, F(E), the
fluorescence signal of interest, and background, B(E):
= +T E F E B E( ) ( ) ( ) (11)
We note that our treatment here contains no corrections for
energy-dependent processes, which might affect the fluores-
cence intensity, such as depth of penetration of the beam into
the sample, although these would be comparatively simple to
include, and would be specific to the case where only one
absorption edge falls within the energy range of the experiment.
The background B(E) consists of contributions from both
elastic and inelastic scattered X-rays, and in the case of
nonenergy dispersive detectors, X-ray fluorescence arising from
absorption edges other than the one of interest. B(E) is
expected to vary smoothly as a function of energy and can be
approximated as a polynomial function of the X-ray energy, E.
A series of equations (eq 10) will be expressed, with different
values of Ii(E), for each incident energy used. All forms
contribute in an essentially chemically insensitive manner to
images at energies that are well above the absorption edge,
whereas below the edge, the intensity will equal the function at
that energy B(E). However, close to or at the absorption edge
itself, the near-edge structure shows considerable variation, and
the intensity at a given energy will be different for each
component. The equations (eq 10) can be solved by matrix
inversion to yield mi, the molar amount of the element present
as species i at each pixel (Figure 22), which can then easily be









The determination of the molar amount mi is dependent on
measurements at all energies, rather than just on the
measurement corresponding to the maximum of intensity of
that component. This allows the separation of species whose
spectra have quite a degree of overlap but which still show
enough distinction that energies can be chosen to confer
chemical sensitivity (e.g., Figure 22, inset). Because this method
requires prior knowledge of the chemical forms present in a
sample and their spectra, it is typically preceded by careful bulk
spectroscopic measurements.29 Chemically specific imaging is
one of the most important and powerful capabilities of X-ray
fluorescence imaging, and while this is still a fairly specialized
method, its use is increasing. There are also a number of recent
reports in which quantitative analysis has been attempted using
difference spectra. Although such numerically trivial approaches
lack the rigor of the treatment described here, useful
information can still be obtained.66
In some cases, and especially at very low X-ray energies,67 it
may be possible to take images using a large number of energies
so that each pixel is represented by what amounts to a complete
Figure 21. Chemically specific imaging of the fern Pteris vittata. The
X-ray absorption spectra of standard solutions of arsenite and arsenate
are compared in (a), and the incident X-ray energies selected for
imaging are indicated as E1 and E2. The tip of one pinna (leaf) was
selected for imaging (b), and the raw imaging data are shown in (d)−
(f) with a micrograph (c), X-ray absorbance (d), and X-ray
fluorescence at E1 (e) and at E2 (f). Using eqs 4 and 5, the analyzed
data in (g)−(i) are obtained, with the concentration of arsenite (g)
and arsenate (h), with maxima of 40 and 2 μM, respectively. The
thickness (i) has a maximum value of 0.2 mm. Adapted with
permission from ref 28. Copyright 2006 American Chemical Society.
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near-edge spectrum. In this case, the number of data values
considerably exceeds the number of species so that the problem
is overdetermined and matrix inversion of eq 10 cannot be used
to give mi values. Early applications used least-squares fitting of
individual pixels to standard compound spectra, but more
recently single value decomposition (SVD) has become
established as the best method for efficiently providing the
least-squares solution (see section 2.10 for a discussion of
SVD).68 An interesting analysis variant has been reported by
Lerotic et al.69 that can be used in the case where standard
compounds are lacking. These workers used principal
component analysis (see section 2.10) in conjunction with
cluster analysis to classify the pixels in an image according to
spectroscopic similarity and to extract representative cluster-
averaged spectra.69
2.7. Three-Dimensional Methods
2.7.1. X-ray Fluorescence Tomography. X-ray fluores-
cence tomography70,71 has been employed increasingly in
recent years,72−74 primarily in an elemental mapping mode to
develop three-dimensional images of elements within samples.
A schematic of a basic fluorescence tomography experiment is
shown in Figure 23, with a micro or nanofocused X-ray beam
penetrating the sample, which is raster scanned along the
direction x and rotated about the angle φ. In some cases, an
alternative and nearly equivalent data acquisition strategy can
be to scan the detector and keep x stationary.74 The X-ray
fluorescence output is monitored as a function of x and φ, and
the resulting sinogram (Figure 23) is subjected to tomographic
reconstruction75 to visualize a cross-sectional slice of the object.
The sample can then be translated vertically along the z
direction (Figure 23) and the procedure repeated to yield
another slice of the object. These can be stacked and combined
for three-dimensional viewing as elegantly demonstrated by de
Jong et al.,76 who conducted tomographic elemental
reconstruction of an air-dried freshwater diatom cell (Cyclotella
meneghiniana) with 400 nm spatial resolution (Figure 24)
following a total data acquisition time of 36 h. Diatoms are
encapsulated by a siliceous frustule. The frustule is often
exquisitely structured, and while this is best viewed in the
scanning electron microscope it is also visible using light
microscopy. The microstructure of the frustule was not
Figure 22. Chemically specific spectroscopic X-ray fluorescence
imaging at the sulfur K-edge. The upper part shows sulfur K-edge
spectra of standard solutions used to analyze the data providing criteria
for selecting incident energies (see markers) E and the values for I(E).
The inset shows an expanded energy scale in the region of disulfides
and thiols/sulfides, illustrating the spectroscopic discrimination
between these forms. The upper row of images corresponds to raw
intensity data for background [F(E1)], total sulfur [F(E6)], and the
spectroscopic peaks of disulfides, sulfides, sulfoxides, and sulfate
[F(E2)−F(E5), respectively]. Processed images showing mole fractions
mi of the different chemical species are shown in the lower part of the
figure. Adapted with permission from ref 29. Copyright 2009 American
Chemical Society.
Figure 23. Schematic of a typical X-ray fluorescence tomography experiment. Parts (a) and (b) show schematic side and plan views, respectively.
The sample is positioned on a stage capable of both rotary and Cartesian motion. It is scanned through x and rotated about φ to develop the
sinogram (c), which can be subjected to tomographic reconstruction of a slice. A number of sinograms at different values of z can be collected, and
their tomographic reconstructions were stacked together to make a three-dimensional rendition of the sample.
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observed by de Jong et al.,76 and while they do not comment
on this, we suspect that it was likely due to the use of an air-
dried sample rather than radiation damage, necessitated by the
pioneering nature of the work. However, as with any X-ray
exposure intensive method, the possibility of radiation damage
is a significant concern, and this is discussed in section 2.11. In
the interests of clarity, we note that coordinate systems
alternative to that shown in Figure 23 are often employed; for
example, the z-direction is often defined as the direction of the
X-ray beam with x being the orthogonal horizontal axis and y
being vertical.
Just as with two-dimensional chemically specific imaging,
chemically specific fluorescence tomography is a practical
experiment, and at least one report has been published.77 An
example is shown in Figure 25, of a seedling of the two-grooved
milk vetch (Astragalus bisulcatus) germinated in 5 mM selenate
solution. Unlike adult plants grown in the absence of selenate,26
seedlings tolerate high concentrations of selenate without any
apparent ill effects. The tomography in this example clearly
shows the selenate in the transport vessels of the seedling with
organic selenium forms in the tissues. We note that μ-XAS in
which an XAS spectrum of a specific voxel can be acquired is
not practical with fluorescence tomography, although this has
been reported for transmittance tomography.72,78 Tomographic
reconstruction artifacts develop if inadequate numbers of angles
φ are collected, and these appear as radial lines (spokes) in
tomographic reconstructions. We note that these are present to
a small degree in Figure 25. Artifacts due to attenuation of the
incident and fluorescent X-rays are not likely to be important
for small samples such as the diatom examined by de Jong et
al.,76 but for large samples correction for attenuation of both
the incident and the fluorescent X-ray beams may be important.
For samples that have significant internal variation in X-ray
cross section, this will be a function both of X-ray energy and of
the orientation of the sample within the experiment, so that
different corrections may be needed for different values of x, φ,
and y (Figure 23), making absorption correction a very
Figure 24. X-ray fluorescence tomography of an air-dried single-celled
freshwater diatom Cyclotella meneghiniana. The silicacious frustule has
been removed to show inner detail. Adapted with permission from ref
76. Copyright 2010 National Academy of Sciences.
Figure 25. Chemically specific fluorescence tomographic reconstruction of a seedling from the selenium hyperaccumulating plant Astragalus
bisulcatus. Absorbance (a) and fluorescence X-ray maps at low (b) and high energies (c) (12 661.08 and 12 667.28 eV, respectively) together with
thickness (d) and chemically specific maps (amounts) for Se-methyl-selenocysteine (e), and selenate (f). The radicle (r) and cotyledons (ct) are
shown in (a). Sinograms for absorbance (g) and fluorescence at low (h) and high (i) energies are also shown. The dotted lines in (a)−(c) show the
z-value used for the tomography. Tomographic reconstruction of the data in (a)−(i) is shown in (k)−(n), the tomogram for Se-methyl-
selenocysteine (k), selenate (l), and transmittance (m). The tricolor plot in (n) compares the localizations of Se-methyl-selenocysteine (red),
selenate (green), and calcium (blue). The circle visible in the tomographic reconstruction of transmittance (m) corresponds to the sample support, a
clear plastic metal-free drinking straw. The faint radial structures visible in the figure are artifacts of the tomographic reconstruction. Data were
collected on SSRL 9-3.
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convoluted problem. Not surprisingly, applications to date have
not attempted rigorous corrections of this type.
2.7.2. Confocal X-ray Fluorescence Detection. This
technique can give three-dimensional information that is very
similar to that from fluorescence tomography and is illustrated
schematically in Figure 26. It has two advantages, that μ-XAS
spectra of specific voxels can readily be recorded, and that
correction for X-ray attenuation is comparatively simple. Its
main disadvantage is that the spatial resolution is often limited
instrumentally in one plane. The method uses two different
focusing optics, one upstream of the sample to generate the
microfocused X-ray beam incident on the sample (as with all
other applications addressed herein) and another placed
between the sample and the detector to restrict the X-ray
light accepted by the detector to a narrow volume where the
two foci intersect (Figure 26). Typically this would be a
polycapillary optic (section 2.1) or alternatively a microchannel
array, which can give a tighter focus yielding a narrower probe
volume (Figure 26), although with the disadvantage that the
distance between the optic and the sample is small.79 The
sample can be scanned, as indicated in Figure 26, to interrogate
a plane and the detector translated toward or away from the
sample to interrogate a different plane. Figure 27 shows an
example of a three-dimensional confocal reconstruction of a
portion of a head of a zebrafish larvae following treatment with
methylmercury chloride. Confocal X-ray fluorescence has been
elegantly applied to probe the elemental composition of
different tissue types in the water flea Daphnia magna.53
2.8. Fluorescence Imaging at High X-ray Energies
Most of the XFI of interest to us in this Review is that
conducted using X-ray energies in the middle to hard X-ray
regime, with incident X-ray energies between 5 and 15 keV.
The upper bound of this energy range is partly governed by the
normal working range of many beamlines with silicon double
crystal monchromators and partly because it is comfortably
above the absorption edges of the majority of biologically
important elements, including all of the first transition row
elements and the p-block elements through bromine. The use
of higher energies, in the vicinity of 33 keV, is common in
synchrotron radiation-based biomedical imaging, often using
iodine-containing commercial intravenous radiological contrast
agents, all of which are substituted 2,4,6-tri-iodobenzoates (e.g.,
diatrizoate or 3,5-bis(acetylamino)-2,4,6-triiodobenzoic acid)
combined with K-edge subtraction (KES imaging) in which
transmittance images above and below the iodine K-edge are
subtracted to improve contrast.80 This method has been
recently applied at lower X-ray energies, such as the Sr K-
edge81 (16.1 keV), but as expected penetration depth is a
restriction.81 The use of high X-ray energies is beneficial relative
to lower energy experiments because the radiation dose is
substantially decreased due to the much lower X-ray absorption
cross sections at high energies, which means that measurements
on live vertebrate animals become possible. The use of iodine
X-ray fluorescence to improve sensitivity at low levels has
recently been explored,82,83 and a combined small animal K-
edge subtraction and fluorescence imaging system has been
developed.83 The major problem at these higher energies and
Figure 26. Confocal X-ray fluorescence experiment. A schematic
diagram of the confocal experiment is shown in plan-view, with a blow-
up of the sample area (inset), illustrating the confocal layer within the
sample that is probed by the combined focal regions of the incident X-
ray beam and the detector polycapillary.
Figure 27. Confocal X-ray fluorescence imaging of a methylmercury-chloride treated zebrafish larvae. The sample is viewed from approximately
midway between the dorsal and ventral surfaces down to the ventral surface. Both volume-rendered (a) and iso-surface-rendered (b) images are
shown, with zinc depicted in green, selenium in red, and mercury in blue. All axis scales are in micrometer relative to an arbitrary zero point. The eye-
lens (el), brain (br), and retina (re) are marked on (a). Data were collected on APS 20ID.
Chemical Reviews Review
dx.doi.org/10.1021/cr4007297 | Chem. Rev. 2014, 114, 8499−85418518
with large objects is that the X-ray inelastic (Compton)
scattering tends to be very broad and extends by several keV,
overlapping and adding a substantial background to the iodine
Kα fluorescence. To alleviate this problem, Zhang et al.
82
developed fluorescence subtraction imaging (FSI) in which
incident beam energies just above and below the iodine K-edge
(e.g., 33.25 and 33.10 keV) are used to obtain a Compton
background image that can be subtracted.82 We note that the
simplest method of removing this Compton background would
be to use an incident energy that is more than 10 keV above the
iodine K-edge, and a similar approach has been employed in Cd
K-edge XFI, discussed in section 3.4.84,85 In cases where the
main method of data acquisition is KES, the use of higher
energies may add more than acceptable time to data
acquisition. Alternatively, beam energies of ∼43 keV may be
outside the working range of the monochromator, and
application of FSI may be the best strategy. Finally, the
advantages of high energies are in lower radiation dose and high
penetration, which are reversed at low energies. Below 2.5 keV,
nearly all of the beam will be absorbed within the first 50 μm of
a sample, and the radiation dose and the potential for sample
damage are correspondingly multiplied (section 2.11).
2.9. Fluorescence Imaging at Low X-ray Energies
Challenges for fluorescence imaging at low incident X-ray
energies (below 5 keV) include several factors not present at
higher X-ray energies. (i) Fluorescence yield (as opposed to
electron yield) is much lower at low energies; (ii) the depth of
penetration is very low, making sample preparation more
problematic; and (iii) when using the near-edge, the energy
separation between scatter and fluorescence peaks is less,
leading to more overlap of these peaks. Conversely, the longer
core-hole lifetimes at lower energies mean that near-edge
spectra are sharper and better resolved, and so are more
sensitive to chemical environment. Thus, the sensitivity of the
sulfur K near-edge spectra allows ready discrimination of a
number of individual chemical types, as we have discussed
above (section 2.6). There are only a handful of XFI beamlines
worldwide that have been specifically designed to operate in the
range 2−5 keV; the ideal beamline in this range would offer all
of high spatial resolution (e.g., <100 nm), high spectral
brightness, and high energy resolution. In most cases,
experiments are conducted in a helium filled flight path with
thin polymer windows, because of the high attenuation of the
X-ray beam by air and other materials, although a small air flight
path has been used in some cases.29 Recent advances at
scanning transmission X-ray microscopy (STXM) beamlines
have added a fluorescence detector capability, effectively
turning them into beamlines for XFI, although in many cases
conducting experiments in the vicinity of 2 keV places STXM
beamlines near their upper operational bound, and occasionally
there are difficulties associated with this. These beamlines
typically operate in a vacuum, and the difficulties associated
with using helium are further compounded. This particularly
rich spectroscopic region shows significant promise as an area
of research growth in the coming years.
2.10. Other Data Analysis Methods
2.10.1. Correlation Plots. The simple expedient of plotting
the levels of two different elements for each pixel in an XFI data
set can often provide important chemical information. Figure
28 shows an example for the XFI of insect larvae (Chironomus
dilutus) showing correlated iron and nickel localization in the
gut, but not with zinc that is localized in the tissues.86 In some
cases, application of a mask in which pixels within a certain
correlation range are specifically selected or suppressed can be
used to reveal more detail.
2.10.2. Principal Component Analysis. XFI data typically
consist of several thousand individual pixels, each with an
intensity corresponding to fluorescence measurements at a
specific physical position on the sample. If the entire output of
an energy dispersive detector is used, each of these pixels has an
associated emission spectrum, itself consisting of between 1024
and 4096 energy points, and if an array detector is used
(section 2.3), these data are accordingly multiplied by the
number of array elements. Thus, the size of the data set can be
Figure 28. Use of correlation plots to show colocalization of two elements, nickel and iron, in the gut of a larval Chironomus dilutus, a species of
nonbiting midge.86 The linear appearance of the nickel versus iron plot indicates correlation and colocalization of the two elements. A correlation
plot of zinc versus iron is also shown, illustrating the appearance when there is little or no colocalization of two elements. Data were collected on
SSRL 10-2.
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considerable; it is not uncommon for gigabytes of data to be
accumulated, and a high resolution image collected using the
Maia detector can approach terabytes in size. However, this
substantial volume of data contains fluorescence contributions
from only a limited number of elements, probably numbering
less than 20, together with the inelastic and elastic scatter, and
background. Because of this, principal component analysis
(PCA) can be used to carry out data reduction. The method
employs single value decomposition (SVD) with data arranged
as a two-dimensional matrix, A, each column containing an
energy dispersive spectrum of n points at a particular pixel.
Spatial correlation is not important in the SVD calculation so
that these spectra are arranged by a pixel index number, up to a
total m, and not as two- or three-dimensional spatially arranged
data. These can be written using a single-value decomposition
in which A is written as the product of an m × n matrix U, an m
× m diagonal matrix V, and the transpose of an m × m
orthogonal matrix W. The matrix U contains columns of
orthonormal eigenvectors, called the principal components, and
V is a diagonal matrix that contains the eigenvalues.
= · ·A U V W t (13)
The principal components (eigenvectors) thus obtained are not
physical component spectra, but instead are mathematical
constructs. As discussed by Vogt et al.,87 the eigenvectors can
be remapped as images to yield what are called the
eigenimages,87 and these can be arranged in order of
significance in the data set, with the data set as a whole being
represented by a comparatively small number of eigenvectors or
eigenimages. The photon noise in the image is not correlated
between pixels and does not contribute to the important
principal components. Moreover, fitting the eigenvectors can
provide images of elemental components without the computa-
tional burden of peak-fitting the emission spectra of single
pixels.87
2.10.3. Soft Clustering Methods. We have discussed in
section 2.6 the “hard” cluster analysis of Lerotic et al.69 This
approach assigns pixels to groups based on a measure of
similarity between pixels. Recently, Ward et al.88 have described
methods using a soft clustering approach employing multiple
Gaussian fits to elemental correlation plots, and assignment of
pixel-probability to groups (each represented by a Gaussian) to
effectively relax group membership criteria. As a test of the
method, Ward et al. compared rigid cluster analysis and soft
clustering with a four Gaussian fit for Fe and Zn levels in XFI
data of the malaria parasite Plasmodium falciparum, and found
that soft cluster analysis could readily discriminate between the
parasite, the parasite’s food vacuole, the host erythrocyte, and
the background.88 In comparison, hard cluster analysis failed to
discriminate these regions.88 The method was found to
accurately segment images into biologically relevant subregions,
and is as accurate as manual image segmentation, but
considerably faster. As pointed out by Ward et al.,88 as the
speed of XFI data acquisition increases, automated methods
such as soft cluster analysis will become increasingly useful.
2.11. Radiation Damage and Prevention
Sample damage due to ionizing radiation such as X-rays is a
recurring theme in studies of biological samples. The worst case
is undoubtedly that of living samples, with vertebrate cells and
tissues representing the extreme in sensitivity. The only report
of XFI of living vertebrates is that of Korbas et al.,89 who
reported XFI of intact living zebrafish larvae maintained under
anesthesia. Invertebrates such as insects and plants are
comparatively resistant and can survive extended exposure
with no apparent short-term effects. In the case of aqueous
samples, the radiation chemistry of water can be a major source
of problems, especially with long dwell times.59 The use of
microfocused X-ray beams gives a very high dose, although this
is countered by the short exposure times generally used in XFI
experiments, especially in rapid scan experiments. For three-
dimensional imaging (either tomography or confocal, section
2.7), preventing dehydration, heating, or beam-damage during
longer data acquisition times can be a particular challenge. With
fixed samples, three common embedding alternatives are
acrylic, wax, and epoxy. Epoxy is traditionally used for electron
microscopy and is appropriately used for very thin sections of
tissue, suitable for the highest XFI resolutions. For more
commonly used XFI resolutions, acrylic and wax are the most
appropriate choices, and of these we have found that acrylic is
the most susceptible to beam damage, showing discoloration
and deformation more rapidly on exposure to beam than the
old-fashioned wax embedding material. Low temperatures are
often employed to prevent beam damage, and a number of
commercial stages designed for other spectroscopic or
microscopic applications, such as the Linkam FTIR600
(Linkam Scientific Instruments, Guildford, Surrey, UK), have
been adapted for XFI experiments.
2.12. Sample Preparation
Sample preparation is one of the most important factors in an
XFI experiment, but has often been neglected in reviews. There
are many issues to be considered, depending on the capabilities
and physical setup of the beamline, the type of sample being
analyzed, and the type of insight being sought. As with most
sample preparations for analysis using synchrotron X-ray
methods, minimal pretreatment is preferred. Chemical pretreat-
ment of samples has the potential to alter the distribution of
elements as well as their chemical speciation, while the
ubiquitous use of phosphate buffered formalin for tissue
fixation is also a confounding factor for phosphorus imaging
and speciation. Early work by Bush et al.90 reported that trace
elements were not influenced by formalin fixation; however,
this has been refuted in later work by Gellein et al. where longer
durations were considered.91 Using ICP-MS, Gellein et al. have
demonstrated that leaching of most elements, such as Mg, Mn,
Fe, Cu, Zn, As, Cd, and Hg, from biological tissue occurs,91
although the most significant changes are largely associated
with long-term storage. Leaching of trace Cr and Ni from
tissues stored in formalin, however, was minimal.91,92
Because of problems encountered with irregular surfaces or
other issues such as edge effects, the surface to be mapped is
typically flat or reasonably uniform, although corrections can be
applied to account for irregularities or structured surfaces. Edge
effects (discussed earlier in section 2.4) can arise in thick
samples or those with irregular or rough surfaces and can result
in an increased fluorescence signal from edges or decreased
signal in an area that is shadowed from the detector or incident
beam, both of which will alter the apparent fluorescence
intensity of the sample. Similar edge effects can arise in
sectioned material, such as the inadvertent introduction of small
wrinkles and folds during collection of cryo-sectioned tissue
onto a mounting medium. For thin sections, this may mean
there are areas within a map of a 10 μm thick section that are
significantly thicker, giving rise to significantly higher
fluorescence and therefore greater apparent areal densities of
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elements within the defect region. Inspection of the X-ray
scatter map can be a useful tool for identifying such edge and
surface irregularities, and in some instances it may be possible
to use the scatter map to normalize data channels during
postprocessing. Szczerbowska-Boruchowska has reported a
detailed investigation of sample thickness effects for quantitia-
tive XFI as well as composition details for reference human
tissues.93
Depending on the necessities of the experiment, samples may
be windowless, with the surface of the sample exposed, or else
they may be sealed, either to prevent dehydration during data
acquisition or to prevent contamination. Windowless is
typically preferred for imaging of light elements, for which
the window material can significantly attenuate the fluorescence
signal and also contribute to X-ray scatter. For soft X-ray
imaging, such as that done using incident X-ray energies in the
vicinity of the sulfur K-edge, enclosure of the sample and
detector within a He-filled container is necessary to minimize
attenuation of the sample fluorescence at these energies. A
proper purge with He is absolutely required following sample
changes with such a setup; otherwise, the attenuation will drift
for a period at the beginning of the scan as the system
equilibrates. In some cases, samples for soft X-ray experiments
can be maintained in air, but in this case the bulk of the
apparatus is contained in a helium chamber with a very small air
gap (ca. 0.1 mm) between a thin polymer X-ray window and
the sample surface to minimize air absorption.29 For similar
reasons, window material containing high atomic number
elements should be avoided as this can also attenuate the
fluorescence signal from the sample arising from lower atomic
number elements.
2.12.1. Sample Preparation/Fixation. X-ray fluorescence
imaging of cells and tissues demands careful consideration of
sample preparation protocol, because measurements are
typically done on ex vivo samples as opposed to living systems.
To avoid misinterpretation of the ex vivo elemental
distributions, which may not reflect the in vivo state, care
must be taken during such steps as anesthetization, the time
between death and tissue fixation (sometimes called that agonal
period), storage and preservation protocols (such as chemical
fixation or cryo-preservation at LN2 temperatures), the method
of tissue preparation, and the analysis conditions (analysis of
fully hydrated tissue at cryogenic temperatures or air-dried and
dehydrated samples at room temperature).
The use of aqueous environments to culture cells, or animal
models that involve small organisms (Caenorhabditis elegans,
zebrafish, etc.), simplifies the choices somewhat. Fixation can
be achieved by passive diffusion with cell cultures or organisms
in liquid fixation or anesthetic media.94−96 However, despite
the simplicity with which chemical fixation can be completed
for cell cultures and small organisms, elemental distributions
particularly for elements such as Cl, K, and Ca that are present
as readily diffusible ions are best obtained by cryo-preservation
and analysis of frozen hydrated samples.97
Increasing organism complexity (e.g., mouse or rat models)
brings increasing complexity to sample preparation and a
greater chance for altering elemental concentrations and
distributions relative to the in vivo state. In larger animals,
simple diffusion of a chemical fixative is not possible, and if
chemical fixation is to be performed it should be done via
perfusion-fixation.98 Perfusion with saline is also often
performed99,100 and has the advantage of removing blood
from the tissue, which can be a major source of iron
contamination. There may be significant drawbacks with this
method, however. It has been established that elements such as
K and Cl that are present as ions are mobilized by aqueous
fixation media and are rapidly redistributed and leached from
biological samples.97,101 The process of perfusion also disrupts
blood supply to tissues, creating ischemic conditions (in-
sufficient oxygen and energy supply), and although no XFI
studies have systematically investigated the changes in
elemental distribution as a consequence of perfusion, it is
known that disrupted oxygen supply drastically alters elemental
distributions in cultured cells.96 It is also well established that
many cell types, particularly brain cells, release intracellular
molecular stores into the extracellular space during perfusion,
which could lead to confounding results. The possibility for
altered elemental distribution during perfusion or perfusion-
fixation of animals should always be kept in mind.
An obvious but often overlooked fact is that buffers and
fixation media must be kept free of exogenous contaminants
that may be inadvertently deposited in tissues, although to our
knowledge few laboratories check perfusion buffers for possible
contamination from trace elements such as metal ions.101
Elevated levels of metals (i.e., Fe, Cu, Zn) are often observed in
formalin-fixed tissues,101,102 which have been demonstrated to
result from metal contamination in the perfusion, fixation, or
buffer media.101 Furthermore, contamination is highly unlikely
to be uniform across biological samples, giving rise to regional
differences in contamination due to different binding affinities
of metals for different tissue types. For example, contamination
of brain fixation media with Fe, Cu, and Zn results in the
greatest increase in Fe and Zn levels in the gray matter, and the
greatest increase in Cu levels in the white matter.101 Therefore,
as significant molecular differences exist between different
tissue types, and possibly between the same tissue type when
effected by different physiological or disease processes, it is not
necessarily valid to assume that consistent sample preparation
across all samples will yield consistent or similar effects in all
samples.
In addition to alterations in elemental distribution as a
consequence of sample preparation, chemical speciation may
also change. Specifically, the results of XFI employing multiple
energies (section 2.6) may be significantly impacted by sample
preparation. Drastic alterations in the speciation of sulfur have
been observed to occur as a consequence of formalin-fixation
(relative to cryo-preserved tissue), and subtle alterations also
occur as a consequence of air-drying tissue sections.103 As
imaging of living cells or tissues is often impractical with XFI,
the possibility for some degree of chemical alteration from the
in vivo state should always be considered, highlighting the
importance for a thorough understanding of the likely chemical
alterations, which may occur with the specific sample
preparation protocol employed.
Although analysis of frozen-hydrated cryo-preserved samples
yields both elemental distribution and chemical speciation
closest to the in vivo state,97,103,104 this method requires
specialized sampling accessories compatible with analysis at
cryogenic temperatures. Implementation of such an approach is
not compatible with all studies (for example, post-mortem
autopsy human tissue), nor with physical or experimental
limitations that may be imposed by the beamline at which the
experiments will be carried out. Biological samples may also be
present in some form of matrix, such as embedded in paraffin
or methacrylate (acrylic). Such embedding media are highly
compatible with XFI, as these matrixes contain low Z elements
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that do not contribute to the energy ranges generally
considered for such experiments. However, as discussed
above, the possibility for altered chemical speciation, elemental
redistribution, leaching, or contamination from the long list of
reagents or preparation steps used in paraffin and methacrylate
embedding processes should always be considered.
2.12.2. Sample Thickness. Samples for biological
applications are usually relatively thin and of uniform thickness.
For cell cultures, for example, monolayers are the preferred
choice as these typically will be on the order of 10−20 μm thick
(per cell) with the resulting image not being complicated by
signal from overlapping cells. Additionally for cell cultures,
nonmotile cells (in the event of live cell imaging) or cells that
have been fixed are necessary as the potentially long scan times
provide ample opportunity for cells to move within the beam.
Larger biological specimens typically are sectioned to the
desired thickness. These sections are often preferred for
quantification as their thickness, and self-absorption issues
can be neglected (see section 2.5).93 Further, as samples can be
mounted at an angle of 45° to the incident beam, loss of spatial
resolution is minimized or negligible if the sample thickness is
comparable to or less than the spatial resolution of the
experiment. However, for dilute levels of trace elements, the
trade-off is reduced sample volume and therefore lower
fluorescence signal (assuming complete penetration of the
incident beam as well as negligible loss of fluorescence signal
escaping from the sample), which results in low signal-to-noise
and necessitates longer dwell times.
2.12.3. Sample Substrate. Samples, especially sections,
must be mounted on some type of support such as a coverslip,
slide, or other reasonably X-ray transparent material. Careful
choice of metal-free, sulfur-free, or halogen-free mounting
material is required, although many commercial vendors will
not be able to ensure their products meet these requirements.
Therefore, screening of mounting materials prior to experi-
ments is always recommended. As a general rule, samples
should be mounted on a material that is thinner than the
sample to be mapped, as this will present minimal background
scatter (e.g., 10 μm thick tissue on 6 μm polypropylene). In
practice, however, good success has been achieved with thicker
mounting materials, such as 20 μm thick tissue mounted on
200 μm plastic coverslips, provided the coverslip is comprised
of low atomic number material (i.e., carbon, oxygen, hydrogen).
Plastic materials often have the advantage of being relatively
inexpensive, durable, and able to accommodate a wide range of
sample types and sizes. Plastic supports supplied by vendors
can have variable levels of trace impurities, such as one instance
in the authors’ experience of commercial “metal-free” micro-
scope mounting materials that contained substantial levels of
cobalt which varied from batch to batch. Conventional glass
materials used for optical microscopy are incompatible choices
for XFI measurements because of their high content of zinc and
other elements; additionally, substantial silicon fluorescence
from glass slides may saturate detectors. Electron microscopy
grids can also be employed; however, careful consideration
must be given to the proximity of the area to be mapped with
the grid, as the gridbars may also contain elements of interest to
the experiment. Silicon nitride (Si3N4) windows are a close to
ideal mounting material from an imaging perspective, are
compatible with cell cultures, and allow a range of
spectroscopic measurements to be performed on the same
sample.105 However, the use of silicon nitride windows is often
limited by their small size (generally 2 × 2 mm2 or 5 × 5 mm2),
their fragile nature, and higher cost.
2.13. Pitfalls and Problems
2.13.1. Overlapping Fluorescence Lines and Contam-
ination. One of the advantages of XFI is that in most cases
elements cannot be confused, as the technique depends on
basic atomic physics. A common question among newcomers
to the technique is whether chemically similar metal ions, such
as Cd2+ and Hg2+, can be confused. In this, and in almost all
other cases, there is no possibility of confusion, as the
fluorescence lines of cadmium and mercury are very well
separated in energy. However, the fluorescence lines of a few
pairs of elements overlap sufficiently that additional measure-
ments are needed to distinguish them. A very well-known and
sometimes encountered example is that of arsenic and lead; the
centroid of the As Kα12 fluorescence is 10 532 eV, which is
insufficiently separated from the Pb Lα12 at 10 518 eV to be
distinguished [note that solid-state detectors cannot typically
resolve α1 and α2 fluorescence lines (section 2.3) and so we
use the intensity weighted centroid of these lines here]. Both
arsenic and lead may be present in a sample, and in addition
lead X-ray fluorescence contamination is sometimes seen due
to lead’s widespread use in beamline radiation shielding. In the
case of discriminating As from Pb, simply changing the X-ray
monochromator to move the incident X-ray energy below the
lead LIII edge at 13 035 eV but above the As K-edge at 11 867
eV would eliminate Pb Lα12 fluorescence without removing As
Kα12 fluorescence, effectively allowing determination of As in
the presence of Pb. Determination of Pb in the presence of As
can also be accomplished by moving the monochromator
energy to above the Pb LII edge at 15 202 eV, which would
excite the intense primary LII fluorescence, the Lβ1 at 12 614
eV; unfortunately confusion of the Lβ1 with the Se Kβ at 12 496
eV is also possible, although the Se Kα12 at 11 209 eV would
clearly indicate the presence of Se. Studies of samples
containing As, Se, and Pb require some care to unambiguously
determine the different elements present. In many cases, simply
changing the monochromator energy will not be sufficient to
eliminate overlaps in fluorescence because of the energy ranges
of the beamline. Thus, hard X-ray beamlines that typically
operate at 10−15 keV may not be able to operate at energies
much below 5 keV. For example, XFI investigation of organo-
tin toxicology might be somewhat problematic on a hard X-ray
beamline because the monochromator would excite all of the L-
edges, with the tin LII primary fluorescence, Sn Lβ1 (3663 eV),
substantially overlapping with the Ca Kα12 (3691 eV). Another
noteworthy case is the proximity of the Zn Kβ (9572 eV) to the
Hg Lα12 (9980 eV); while these are easily resolvable, Zn can be
so abundant in biological samples that the tail of the Zn Kβ can
add a background to the Hg Lα12 and confuse inattentive
researchers, especially if simple binning is used.
Components of the beamline can give rise to contaminating
signals that may confuse the analysis. Examples include iron,
lead, copper, bromine, and antimony. As discussed above, lead
is found in shielding and is second only to iron, which is
present in a very large number of beamline components,
including most vacuum-compatible X-ray windows fabricated
from beryllium, the element of choice due to its low X-ray cross
section. The authors have also encountered copper contami-
nation arising from exposed wiring internal to a new array
detector, which was subsequently returned to the manufacturer
and the problem eliminated. Bromine at first seems a somewhat
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unlikely contaminant, but it is often present in plastics such as
acrylics, because ethyl 2-bromoisobutyrate and ethyl 2-
bromopropionate are used as polymerization initiators.106
Similarly, antimony compounds such as antimony trioxide
(Sb2O3) or antimony triacetate are used as condensation
catalysts in the production of poly ethylene terepthallate
(PET).107 PET is most commonly found in plastic bottles used
to contain drinks such as bottled water or carbonated
beverages, and we note in passing that antimony leaching
from PET is a potential source of exposure to compounds of
this highly toxic element.108 PET is often used in plastic
coverslips as sample supports in XFI, and if used for this
purpose care must be taken to obtain antimony-free PET as the
Sb Lα12 (3604 eV) and Ca Kα12 (3691 eV) overlap enough to
make determination of biological calcium difficult.
2.13.2. X-ray Fluorescence Self-Absorption. The
phenomenon known as fluorescence self-absorption is an
attenuation of the X-ray fluorescence due to high X-ray
absorption coefficient, and is only a problem for concentrated
samples that are also thick. The common description of this
phenomenon as “self-absorption” is somewhat inaccurate, and it
could also be referred to as fluorescence thickness effects.
Although thickness effects, including self-absorption, are
discussed at length in section 2.5, we mention self-absorption
briefly here because it represents a potential pitfall. With
adequately dilute or thin samples, the X-ray fluorescence from
the sample is proportional to the absorption coefficient μ(E),
eq 3, which is the condition desired. In most cases, X-ray
fluorescence self-absorption can be avoided with good
experimental practice, especially with biological samples that
are usually in the dilute limit. In some cases, however, self-
absorption may be unavoidable, such as calcium from bone in
sections of whole animals, and comparison with optically thin
standards must be done with care.
3. APPLICATIONS IN THE STUDY OF PLANT
PHYSIOLOGY
Plants were used in many of the early XFI studies of living
systems. While plants are interesting in their own right, early
XFI studies were enabled by the fact that plants are highly
resistant to radiation damage from the X-ray beam so that they
often can be observed in a living state. Moreover, no protocols
are required for their study, minimizing paperwork and
eliminating ethical review, which is mandatory for animal and
human tissue work. Applications of XFI to metal ion plant
physiology have recently been reviewed at length by Sarret et
al.,109 and for this reason we will only discuss selected topics to
provide examples. For a more comprehensive review, the reader
is referred to Sarret et al.109
3.1. Hyperaccumulating Plants
Of particular note in the field of plant metal ion physiology are
those plants known as hyperaccumulators, which can assimilate
very high levels of metals or metalloids from their environment.
They are of interest with respect to the bioremediation method
called phytoremediation,110,111 in which plants are used to
sequester or modify an environmental contaminant, thereby
alleviating an environmental problem without the need for
excavating large amounts of soil or rock. The levels of
accumulation can be quite extreme; for example, the New
Caledonian tree Sebertia acuminata can have vivid blue-green
latex due to its startlingly high nickel concentration of about 2
M.112,113 Other examples include the nickel hyperaccumulating
penny-cress Thlaspi goesingense,114,115 the arsenic hyperaccu-
mulating brake fern Pteris vitata,28,60,61,116 and the selenium
hyperaccumulating two-grooved milk vetch Astragalus bisulca-
tus.117 Some tropical trees accumulate selenium in their tissues
to a surprising extent, including the brazil nut tree (Bertholletia
excelsa), which concentrates L-selenomethionine in the nuts,118
and the Coco de Mono or Monkey Pot tree (Lecythis
ollaria).119−121 The nuts of the Coco do Mono tree, also
known as Paradise Nuts, have a very high L-selenocystathionine
content,122,123 and are a noteworthy source of human toxic
exposure to selenium, possibly due to their agreeable taste.
Kerdel-Vegas has described a number of case histories of people
who consumed Coco de Mono nuts, nearly all of whom were
warned by locals of dire consequences but nonetheless ate the
nuts, with the unpleasant symptoms of selenium intoxication as
their reward.120 Because the first and one of the best-studied
hyperaccumulator plants is A. bisulcatus, we will initially discuss
XFI of selenium hyperaccumuators.
3.2. Selenium Hyperaccumulators and Accumulators
Selenium hyperaccumulation was first noted by Moxon in the
1930s,124 while investigating the cause of the livestock disease
called the “blind staggers” or “locoism”. The blind staggers are
now thought of as several unrelated diseases in which an
unsteady gait and seeming blindness are apparent. In the North
American plains, a common cause may be selenium intoxication
from ingestion of selenium hyperaccumulating range plants,
including certain Astragali (in particular A. bisulcatus), Aster,
Stanleya, and Oonopsis.124 While selenium intoxication by
feeding animals A. bisulcatus does produce the symptoms of the
blind staggers,125 O’Toole et al. have criticized the hypothesis
that the bind staggers are due to selenium, but they also
comment that it is not yet discredited.126 The two-grooved milk
vetch A. bisulcatus can take up selenium from the soil;127 it is
accumulated as a mixture of Se-methyl-seleno-L-cysteine and γ-
glutamyl-Se-methyl-seleno-L-cysteine.128 These compounds are
generated from seleno-L-cysteine by a specific selenocysteine
methyltransferase.129 A. bisulcatus is also known as the poison-
vetch and by cattle ranchers as “locoweed” due to its association
with the blind staggers. The first XFI study of any
hyperaccumulating plant was of A. bisulcatus, by Pickering et
al.,50 who showed that the plant stored different forms of
selenium in leaves of different ages. Newly grown or young
leaves were found to contain high levels of Se-methyl-seleno-L-
cysteine, while older mature leaves contained predominantly
selenate. Leaves of intermediate age were found to contain a
mixture of these species. Pickering et al. also reported that the
overall selenium content of the leaves decreased with their
age.50 Some Astragali are well-known for their malodorous
nature, which is due to loss of volatile selenium compounds,
among which dimethyldiselenide is prominent.130 Pickering et
al. have also reported that there is correspondence between
sulfur and selenium chemical forms in old and young A.
bisulcatus leaves.131 It has long been thought that selenium
hyperaccumulation might be a defense mechanism aimed at
insect herbivores, and it seems likely that the production of
volatile selenium compounds such as dimethyldiselenide130
plays a role in this. The mechanism by which dimethyldisele-
nide is generated from Se-methyl-seleno-L-cysteine is still
unknown, but Pickering et al. noted that both are relatively
nontoxic as compared to selenate, the other major selenium
species present. These workers also commented that the young
leaves in which these less toxic forms predominate are those
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that the plant can least afford to lose, but that the foul smell of
the volatile selenium species might serve to redirect
herbivorous insects to the older, less pungent, but more toxic
leaves. Freeman et al. have expanded this early work, and also
studied a different selenium hyperaccumulator, a mustard
known as prince’s plume (Stanleya pinnata).132 They used XFI
with improved spatial resolution to show that organic selenium
was concentrated in the trichomes (leaf hairs) of plants thought
to be A. bisulcatus. These workers also harvested large numbers
of trichomes, and employed conventional analysis to show that
this was Se-methyl-seleno-L-cysteine and γ-glutamyl-Se-methyl-
seleno-L-cysteine.132 Se-methyl-seleno-L-cysteine was found to
be present in the vascular tissues of a S. pinnata young leaf
petiole as well as in guttation fluid.132,133 These results contrast
with the results of Pickering and co-workers26 (also including
unpublished data), who did not find organic selenium in the
trichomes but did observe selenium within cells, and found high
levels of calcium in the trichomes (Figure 10). The two groups
used different culture methods; Freeman et al. used a
commercial horticultural growing mix,132 while Pickering et
al. used hydroponic growth media.50,131 The plants were also
harvested from different locations; Freeman et al. obtained
theirs from Fort Collins, CO, and Pickering et al. from Big
Hollow, WY, and from Saskatoon, Saskatchewan, Canada.
Moreover, Freeman et al. did not observe calcium in the
trichomes of plants identified as A. bisulcatus,132 but did for the
trichomes of the nonhyperaccumulator Indian mustard, Brassica
juncia. Given that large numbers of related vetches of similar
appearance exist, it seems plausible that one group or other
misidentified A. bisulcatus, and that two discrete species were in
fact studied. At present, more work is required to resolve this
discrepancy. More recently, XFI has been used to examine
Astragalus roots134,135 and two Se-resistant herbivorous moths,
one of which was parasitized by a wasp.134,136 XFI of the adult
moths, larvae, and wasps showed that each accumulated organo
selenium compounds, with no apparent ill effects. The studies
of roots showed that elemental selenium producing endo-
symbionts may be able to affect selenium speciation in
hyperaccumulators.134,135
In contrast to the selenium hyperaccumulators, which have
special selenium biochemistry, selenium uptake by non-
hyperaccumulating species appears to be solely as a
consequence of the similarities between sulfur and selenium
chemistry.137 Thus, selenate uptake is thought to occur through
sulfate transporters, and selenate reduction is thought to occur
via the normal route for sulfate, involving the ATP sulfurylase/
APS reductase pathway.137 In nonhyperaccumulating plants, a
predominant form in tissues is often L-selenomethionine.138
While a number of studies have been directed at phytor-
emediation,138 XFI has been used to investigate the physiology
of selenium uptake and enrichment in putative biofortified food
plants,139,140 a particularly interesting application may be
ordinary crop plants141 grown on naturally selenium-rich
areas as a potential selenium supplement for parts of the
world that are selenium deficient.142
3.3. Arsenic Hyperaccumulators and Accumulators
Arsenic accumulation and hyperaccumulation is rare among
plants, and is only known for a handful of ferns, of which Pteris
vittata is the most noteworthy.28,60,61 Pickering et al.28 used
chemically selective XFI to show that the chemical form present
in the transport vessels was arsenate (a mixture of [HAsO4]
2−
and [H2AsO4]
− at physiological pH), which was transformed to
arsenite (As(OH)3) in the tissues (Figure 29). They also clearly
detected a small amount of thiolate coordinated As(III),28
which had been previously observed in bulk measurements.60
Pickering et al. hypothesized that this was an intermediate in
the reduction of the As(V) arsenate to arsenite.28 By enhancing
the intensity threshold, Pickering et al. observed a line of
arsenite following the periphery of the arsenate-containing
transport vessels,28 which suggested transport of arsenite from
the photosynthetic tissues to the rest of the plant. The same
species of fern was subsequently studied using XFI by Hokura
et al.,143 who used large area imaging to view substantial parts
of the plant. Recently, a different hyperaccumuating fern, the
gold dust fern Pityrogramma calomelanos var. austroamericana,
has been studied using XFI by Kachenko et al.144 These
workers also observed arsenate in the transport vessels, and
detected thiolate coordinated species in the tissues. The clear
physiological picture that is apparent from these studies is that
arsenate is taken up from the soil by the roots and transported
through the vascular tissue from the roots to the fronds
(leaves), where it is reduced to arsenite and stored at high
concentrations. The arsenic-thiolate species surrounding veins
may be intermediates in this reduction. The life cycle of the
fern145 can be described in terms of two discrete generations;
the familiar leafy fern is the diploid sporophyte generation that
generates haploid spores through meiosis. These spores are
contained in capsules known as sporangia, which in turn are
localized within spore dispersal regions called sori on the
underside of mature fronds.145 Following dispersal and
germination, the spores develop into small free-living photo-
synthetic haploid gametophyte plants,145 only a few millimeters
across and one cell thick throughout most of their structure,
which develop sperm within antheridia and egg cells within
archegonia. Fertilization results in a new sporophyte plant,
which grows directly through the gametophyte.145 In addition
to examining the sporophytes, Pickering et al. also examined
Figure 29. Chemically specific X-ray fluorescence imaging of Pteris
vittata, showing the presence of arsenate in the transport vessels, and
biotransformation to arsenite in the tissues.28 The figure shows XFI of
the highlighted area in the optical micrograph, showing a central rachis
(stem) with two branching rachilla supporting the pinnae (leaves).
Arsenate is depicted in red, arsenite in green, and the derivative of the
transmittance-derived thickness t in blue. The derivative of t is shown
rather than t itself so as to better indicate the tissue periphery. Adapted
with permission from ref 28. Copyright 2006 American Chemical
Society.
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the sporophyte sporangia and gametophytes of Pteris vittata.28
In both cases, the reproductive tissues, or the areas in which
reproductive tissues would develop, were found to be free of
arsenite. Figure 30 shows the XFI data of the P. vittata
sporangia and a typical gametophyte. Thus, in the sporophyte
sori and vicinity, arsenite is excluded from the spores and the
sporangia, but it is preferentially concentrated within the
paraphyses (Figure 30), sterile hair-like structures adjacent to
but not directly associated with the sporangia. Arsenite also
accumulates within the pseudoindusium, the reflexed margin of
the lamina that partially covers and protects the sori. Exclusion
of toxic arsenite from the plant reproductive tissues may be
needed to protect these from genetic damage.28 The images of
the gametophyte also give clues to the subcellular localization
of arsenite. Plant cells typically have a large centralized vacuole
with the majority of the cytoplasm contained in the
periphery;145 the images clearly show arsenite localized within
the central cellular vacuole. Arsenate levels are very low in the
gametophyte and, as suggested by Pickering et al., may be
confined to the numerous plant cell Golgi bodies, but further
high-resolution imaging is needed to determine this.28
3.4. Cadmium Hyperaccumulators and Accumulators
Cadmium is generally thought of as a toxic element and has a
demonstrated functional role in only a single case, in a carbonic
anhydrase of the marine diatom Thalassiosira weissflogii.146
Cadmium hyperaccumulators are included here as a further
example, primarily because they provide an example of an
element where relatively inconvenient X-ray energies are
involved. The cadmium K-edge at 26 714.0 eV is high for a
conventional XFI experiment (section 2.8), although still within
the reach of many beamlines, and the LIII and LII-edges at
3537.6 and 3728.0 eV, respectively, are close to our lower
bound in X-ray energy (section 2.9). The high X-ray energies of
the K-edge mean that short core-hole lifetimes give broad near-
edge features,147 which in turn means that any chemical
differences give changes in the spectra that are quite subtle and
difficult to exploit. Conversely, the LIII and LII-edges are at low
energies,147 and so the problems we have previously discussed
associated with beam attenuation will be prominent. Moreover,
the Cd Lα12 and Lβ1 fluorescence lines at 3133 and 3317 eV,
respectively (the primary lines of the LIII and LII edges,
respectively; Figure 8), are inconveniently close to the Kα12 of
biologically common potassium at 3313 eV. Cadmium is
therefore an element that poses some challenges for XFI, but
despite this the method has been used to provide important
information on cadmium in both hyperaccumulating and
nonhyperaccumulating plants.
Early work on the nonhyperaccumulator Brassica juncea
identified that Cd was bound by sulfur donors in the root and
by hard ligands such as oxygen or nitrogen in the xylem sap
with transpiration-driven mobilization into the leaves.148 This
work also conclusively showed that Cd was localized in
trichomes, but rather than XFI these investigators employed a
combination of109Cd autoradiography to probe localization and
Cd K-edge XAS to probe the chemical form.148 Subsequent
XFI combined with μ-diffraction of the nonhyperaccumulating
tobacco plant (Nicotiana tabacum L.) showed that when Cd2+
was given in the presence of excess Ca2+, Cd-containing
crystalline deposits were exuded from the tips of trichomes.149
The accumulator willow (Salix sp.) has been explored as a
potential cadmium phytoremediator; XFI has been used to
show accumulation of cadmium at the tips of the serrations in
leaves, and in the bark.150,151 Tian et al.152 have used both XFI
and LA-ICP-MS (section 5.2) to compare hyperaccumulator
and nonaccumulator ecotypes of Sedum alfredii. This study
showed that the hyperaccumulator S. alfredii ecotype
accumulates cadmium in parenchymal cells, especially in the
stems, but that cadmium was restricted to the vascular bundles
in the nonhyperaccumulating ecotype.152 Tian et al. also
showed a distinctive correlation between the levels of cadmium
and calcium, but not cadmium and zinc, in the hyper-
accumulator,152 and used EXAFS spectroscopy to show that
cadmium was bound by oxygen donors.152 These workers
suggested that cadmium metabolism in the hyperaccumulating
S. alfredii is associated with calcium pathways, and that the
metal is bound with oxygen donors from malate.152 Elegant
studies using Cd K-edge XFI of the cadmium hyperacculator
Arabidopsis halleri spp. gemmifera with an incident X-ray energy
of 37 keV also clearly showed cadmium in the trichomes.84,85
XFI indicated that Cd was localized in highly specific regions
within the trichome, bilaterally disposed, straddling the stem of
the Y-shaped trichomes, just below the branch.85 Moreover, the
Cd was colocalized with manganese and zinc, but not with
Figure 30. X-ray fluorescence imaging of Pteris vittata reproductive
tissues.28 In the figure, (a), (c), and (e) show optical micrographs, and
(b), (d), and (f) show XFI images with arsenate in red, arsenite in
green, and thickness (transmittance) in blue. The sporangia of the
sporophyte generation are shown at different resolutions in (a)−(d)
and the gametophyte in (e) and (f). The future site of archegonial
development is shown in (f) (ar), and several rhizoids (rh) are visible
in (e). Adapted with permission from ref 28. Copyright 2006
American Chemical Society.
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calcium, and μ-XAS showed that, as in other species, Cd was
bound to hard ligands such as oxygen or nitrogen.85
Pickering et al. have suggested what may be a general rule,28
which is that the chemistry underlying hyperaccumulating
plants, or plants otherwise adapted to high levels of metal or
metalloids, lacks sulfur coordination but instead shows binding
by oxygen or nitrogen.153,154 This appears to be true even for
chemical species that have an inherently high affinity for
thiolates, and chalcogenides in general, such as the arsenite
stored in P. vittata.28 Conversely, sulfur is often involved when
plants that are poorly adapted to toxic metals are
exposed.155−157
4. APPLICATIONS IN THE HEALTH SCIENCES
XFI is finding increasing application in the field of health
science. Examples include characterization of disease and
dyshomeostasis, as well as molecular therapy and correlation
with other imaging modalities, with XFI providing fresh insights
into such critical topics as heavy metal toxicology, Alzheimer’s
disease, amyotrophic lateral sclerosis, stroke, and multiple
sclerosis. We will review pertinent examples taken from each of
these fields.
4.1. Mercury Toxicology
The compounds of mercury in general are more toxic than
those of any other nonradioactive heavy element (Figure 31).
Despite this extreme toxicity, human and environmental
exposure is surprisingly widespread, with significant sources
ranging from dental amalgam to predatory marine fish.
Moreover, despite widespread human exposure and health
concerns for many populations worldwide, there remain many
unanswered questions about the mechanism of action of
mercury and its compounds. As a further consequence of its
high toxicity, mercury levels in biological tissues are usually very
low, making this a difficult element to study. Added to this, the
mercury LIII near-edge shows only subtle spectroscopic
variability with chemical form. These issues combine to
effectively make studies of mercury toxicology particularly
challenging. Two broad chemical forms are of interest, the
inorganic form, exposure to which might arise from industrial
activities or from dental amalgam, and the organometallic form,
found in marine fish, which is known to be predominantly
monomethylmercury covalently bound to a single aliphatic
thiolate (probably L-cysteineate).158 Methylmercury com-
pounds are some of the most dangerous neurotoxicants
because they can cross both the blood−brain barrier and the
blood−placental barrier, accumulating in the brain and resulting
in severe damage. Indeed, while under some circumstances the
placenta can provide protection against other toxic metal
species, such as thallium,159 the consequences of in utero
exposure are particularly disastrous for the developing fetus.
The toxic potential of mercury is demonstrated most
graphically by large-scale catastrophic acute mercury poisonings
that have occurred in Japan and in Iraq.160 These tragic
incidents revealed the insidious and debilitating nature of
mercury poisoning with its creeping but deadly neurotoxicity,
particularly in fetuses and young children.160−163 While adults
can be severely impacted by methylmercury exposure, effects
on the developing fetus are devastating, and can result in
microcephaly, cerebropalsy, seizures, mental retardation, blind-
ness, paralysis, and other very severe consequences.164 The
extreme toxicity of methylmercury to vertebrate fetuses was
unknown until the Minamata mass-poisoning, where many
severely handicapped children were born to relatively healthy
mothers.163 Numerous additional consequences of mercury
poisoning include central nervous system defects, arrhythmias
and cardiomyopathies, and kidney damage. Mercury inhalation
can result in necrotizing bronchitis and pneumonitis that in
turn can result in respiratory failure.160,161 Mercury can also act
as either an immunostimulant or an immunosuppressant,
depending on the nature of the exposure, leading to a number
of pathologic consequences.160,161 One of the most perplexing
phenomena in the toxicology of methylmercury species is that
there can be significant latency between administration and
onset of toxic symptoms,165 which in humans can be as long as
150 days.166 The cause of this latency remains one of the major
unanswered questions in this field, and while different possible
mechanisms have been suggested,165 at present the cause
remains unknown. The toxicology of mercury and methyl-
mercury has been studied by XFI of larval stage zebrafish as an
animal model and of human brain samples.
Larval zebrafish (Danio rerio) are increasingly used as a
model organism to study embryonic development. Their many
advantages include high fecundity, ease of maintenance, and
well-characterized developmental stages. They are easily treated
with exogenous agents by simple addition to their habitat water.
Zebrafish are used increasingly in vertebrate toxicology167 and
by the pharmaceutical industry for de facto first-pass drug
screening.168 Korbas et al. used XFI of both anaesthetized
larvae and prepared sections to show that fish treated with
methylmercury-L-cysteinate accumulate Hg preferentially in the
outer layers of eye lens (Figure 32).89 This compound was
selected in initial studies because of its stability in aqueous
solution, so that the larvae were presented with essentially a
single molecular entity. The comparison of the XFI of
anaesthetized and fixed sectioned specimens indicated that no
large-scale redistribution of the metals had been caused by the
sample preparation.89 These workers also observed differential
mercury accumulation in the brain and various other organs.
Subsequent work studied the dynamics of methylmercury
accumulation and redistribution in the lens following
embryonic and larval exposure.169 The accumulation of
mercury in the lens continued well after removal of the fish
from treatment solutions, thus significantly increasing the
postexposure loading of mercury in the lens. This indicated that
Figure 31. A comparison of the relative toxicities of some heavy
elements that pose human health problems. Toxicities are expressed as
the reciprocal of values of the LD50 (rat, oral, mg/kg) taken from
MSDS forms (Sigma-Aldrich, Acros Organics) for a common toxic
inorganic form of each metal or metalloid. The compounds used were
as follows: Na2CrO4, NaAsO2, Na2SeO3, CdCl2, SnCl2, HgCl2, and
PbCl2.
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mercury is redistributed from the original target tissue to the
eye lens, identifying the developing lens as a major sink for
methylmercury in early embryonic and larval stages. Subse-
quent comparative XFI work revealed substantial differences in
the tissue-specific accumulation patterns of mercury in zebrafish
larvae exposed to four different mercury formulations in
water.51 For nonthiolate coordinated mercury compounds,
multiple species are expected to be present in solution, and
Korbas et al. calculated the expected species distributions for
the four reagents added to the fish culture water (HgCl2,
CH3HgCl, Hg(L-cysteineate)2, and CH3Hg-L-cysteineate).
Thus, for 1 μM HgCl2 solutions, Korbas et al. calculated that
solutions would consist of 90.0% Hg(OH)2, 9.5% Hg(OH)Cl,
0.3% HgCO3, and 0.2% HgCl2. XFI showed that methyl-
mercury species exhibited higher mercury uptake and targeted
different cells and tissues than inorganic mercury, revealing a
significant role of speciation in cellular and molecular targeting
and mercury sequestration. For methylmercury species, the
highest concentrations of mercury were observed in the surface
of the eye lens, independent of the formulation ligand. For
inorganic mercury species, the olfactory epithelium and kidney
accumulated the greatest amounts of mercury.51 However, with
Hg(II)-bis-L-cysteineate, uptake was significantly decreased.
This work showed that the common differentiation between
organic and inorganic mercury is insufficient to determine the
toxicity of various mercury species. To determine whether
physical chemical factors alone could account for the chemical
sensitivity observed with XFI, Korbas et al. estimated diffusion
coefficients and membrane permeabilities for all of the
significant solution species present for each treatment
Figure 32. XFI of mercury in methylmercury-L-cysteinate treated zebrafish larvae. Part (a) shows an intact tricaine-anesthetized larva showing
localization of Ca, Zn, and Hg plus an optical micrograph (opt); the developing fish otoliths are prominent in the Ca image. Part (b) shows a typical
head section displaying the same chemical elements, plus a histologically stained optical micrograph together with a line rendition of the stained
micrograph showing the cornea (co), eye-lens (el), retina (re), optic nerve (on), and the fore-brain (br) (diencaphalon). Intensity scales are shown
with linear scaling (lin), and with logarithmic scaling (log) to allow better visualization of the lower intensities. Part (c) shows a high-resolution image
of the surface regions of the eye lens indicating that the mercury is localized in a layer beneath the lens epithelium (ep). Data were collected on SSRL
9-3 (a),89 APS 20ID (b),51 and APS 2ID (c).15
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group.51 They concluded that a simple passive diffusion model
of the compounds across the lipid part of the cell membranes
cannot explain the differential accumulation of inorganic and
organic mercury observed by XFI, so that other processes such
as active transport must play a role. Most recently, high-
resolution XFI has been used to study the uptake and
localization of methylmercury species in larval zebrafish
photoreceptors.15 This work addressed a long-standing
assumption, which is that the visual disturbances that are a
known symptom of organo-mercury exposure were due to
damage to the visual cortex of the brain. The XFI study showed
that photoreceptors take up methylmercury compounds
directly, indicating an additional possible mechanism by
which methymercury species might cause visual disturbances.15
XFI has also been used in conjunction with XAS to study
samples of human brain following poisoning or environmental
exposure.170 Samples from individuals poisoned with high levels
of methylmercury species showed high levels of both mercury
and selenium colocalized in the gray matter, with a substantial
fraction of nano-particulate mercuric selenide (HgSe) together
with inorganic mercury and methylmercury bound to organic
sulfur. Mercury exposure did not perturb observed organic
selenium levels. Individuals with a lifetime of high fish
consumption showed much lower HgSe levels and dominant
methylmercury-L-cysteineate. These results provide the first
evidence that HgSe formation may act as a detoxification
mechanism in humans, at least under conditions of acute
exposure.
XFI has provided evidence that may challenge the perceived
benign nature of mercury amalgam dental restoratives. Loss of
Hg and biotransformation of mercury from amalgam fillings has
been observed,171 and Harris et al.172 have used XFI to show
that Hg can be detected several millimeters away from the site
of the filling, associated with dental tubules, and that the
chemical form of Hg had also been altered.172 Their work also
identified potential routes of exposure to Hg from fillings, as
Hg was localized in the calculus (suggesting it may at one time
have been in a mobile form within the mouth) and highly
innervated areas of the tooth with circulating blood flow,
potentially affording a route to enter the bloodstream.
To date, almost all of the studies on mercury toxicology to
date have employed acute mercury exposure, in which
organisms experience relatively high doses for a short time.
However, most human and environmental exposure is chronic
in nature, involving much lower doses over considerably longer
exposure times. Whether the lessons learned from acute
exposure can be translated to the chronic case remains unclear.
Irrespective of this, the high sensitivity and specificity of XFI
will ensure that it will continue to play an essential role in
understanding the risks posed by this most problematic and
enigmatic of the toxic elements.
4.2. Arsenic Toxicology
As compared to mercury, arsenic is an element that is very well
suited to study by XFI, with a K-edge energy convenient for
most beamlines and a rich and highly structured spectroscopy.
Despite its reputation as a deadly poison, it is very much less
toxic than mercury (Figure 31), which means that rather higher
levels can be tolerated, with a consequence that it is much
easier to study. Also, in contrast to mercury, at least insofar as
acute toxicity is concerned, the mechanism of arsenic toxicity is
relatively well understood, so that there are fewer fundamental
questions that need to be answered. Arsenic, as the trivalent
arsenite, is the most toxic environmentally common form of the
element. It is often written as [AsO2]
−, although no such
molecular entity actually exists,173 and more correctly as
As(OH)3 (at physiological pH). Similarly to mercury, As(III)
has a high affinity for thiols; in acute toxicity, arsenite acts as a
respiratory poison by chelation of essential dithiols and in
particular reduced α-lipoic acid in the pyruvate dehydrogenase
complex to form a stable six-membered chelate ring. Arsenic-
based chemical warfare agents owe their lethality to the same
mechanism.174 Chronic arsenic exposure, for which the
mechanisms of action are comparatively poorly understood,
poses enormous human health problems for communities in
developing countries that consume contaminated drinking
water. Such exposure results in arsenicosis, a syndrome
featuring characteristic patterns of hypermelanosis and hyper-
keratosis, vascular and endocrine pathologies, several types of
cancer, and increased mortality.175 While the biochemical
mechanisms underlying arsenicosis are still substantially
unknown, arsenic is a known carcinogen; there is extensive
literature that links human exposure to inorganic arsenic with a
variety of cancers, including lung cancers,176 skin cancers,177
and urinary bladder carcinoma.178 Moreover, arsenic may act as
a cocarcinogen in urinary and bladder cancer with cigarette
smoking178,179 and in skin cancer with UV light exposure, even
at low levels.180,181 Several possible modes of action may be
involved in arsenic carcinogenesis,182 but the underlying
mechanisms remain poorly defined. Probably in excess of 100
million individuals worldwide have severe health impacts from
arsenicosis, with the crisis in Bangladesh representing an
extreme example. There are thus many areas of arsenic
toxicology in which XFI could make a significant impact,
although to date only a few XFI studies of arsenic in animal
systems have been reported, including some studies of
insects,62 with most vertebrate data limited to such samples
as fur and feathers.183 Insofar as studies relevant to human
health are concerned, Munro et al.184 used XFI and μ-XAS to
investigate the fate of arsenite and arsenate in cultures of
human liver carcinoma cells (HepG2) and observed accumu-
lation in the euchromatin region of the cell nucleus following
arsenite exposure, which suggested arsenic targeting of either
DNA or proteins involved in DNA transcription. μ-XAS and
XAS of arsenite-treated cells showed predominance of arsenic
sulfur-coordinated species, supporting the hypothesis that the
mechanism of action may concern nuclear proteins, that this
occurs through arsenic’s affinity for chalconide donors, and that
this nuclear interaction may be a key factor in arsenic-induced
toxicity.
Arsenic and selenium have long been known to have
intertwined toxicities,185,186 wherein a lethal dose of arsenic can
be counteracted by an equal and otherwise lethal dose of
selenium.186 The mechanism of this surprising antagonism was
found to be the formation of a novel arsenic selenium species,
the seleno-bis(S-glutathionyl) arsinium ion,187 which is formed
in the liver187 and possibly in erythrocytes188 and excreted in
the bile,189 probably through the MRP2 transporter.190 The
organic selenium compound 1,4-phenylene bis(methylene)-
selenocyanate and vitamin E have both been shown to block
the cocarcinogen activity of arsenic in mice with ultraviolet
irradiation, although only vitamin E had beneficial effects with
ultraviolet irradiation in the absence of arsenic.191 XFI has been
used to probe this protective effect of selenium; Burns et al.
found elevated levels of arsenic were present in hair follicles and
epidermis of mice treated with both arsenite and ultraviolet
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light, yet when 1,4-phenylene bis(methylene)selenocyanate was
given, arsenic was entirely absent in these tissues, with only
diffuse low levels in the liver.192 Arsenic K near-edge μ-XAS of
the liver was consistent with the presence of the seleno-bis(S-
glutathionyl) arsinium ion, suggesting that the mechanism
underlying the protective effect of selenium in arsenic/
ultraviolet cocarcinogenesis was through removal and biliary
excretion of arsenic.192
An intriguing example in which XFI provided critical
information is that of Phar Lap. Phar Lap was a successful
and famous racehorse that ran between 1929 and 1932, gaining
acclaim for a spectacular series of wins. He became a cultural
icon of the Australian sporting community, but while in
California he died suddenly and painfully following a
spectacular win in Mexico. While poisoning was suspected,
necropsies were inconclusive, and Phar Lap’s death remained a
mystery for nearly eight decades. Phar Lap’s hide is preserved
on display at Melbourne Museum, and a recent XFI and μ-XAS
study used hair taken from the preserved hide to partly resolve
the mystery.193 Because of Phar Lap’s symptoms, arsenic was
suggested early as a possible poison. However, providing
conclusive evidence of this proved difficult because arsenic can
be used in taxidermy and in the 1930s routinely was
administered as a tonic to race horses, in the form of Fowler’s
solution. Kempson and Dermot used XFI to study Phar Lap’s
hair, employing four samples that included intact bulb and root
tissue.193 Longitudinal scans indicated low arsenic levels within
the hair but with an abrupt rise in the subcutaneous region
followed by decrease in level toward the root tip, consistent
with a large dose followed by a slow decay due to metabolism
and excretion.193 Kempson and Dermot also detected external
arsenic that had likely been applied during taxidermy, but at
much lower levels than that contained within the hair. The
subcutaneous arsenic-rich regions of the hair were shown by μ-
XAS to contain As(III) coordinated by three thiolates,193 which
would be expected if the poison was administered as arsenite or
arsenic trioxide. The study showed that Phar Lap had received a
sudden and substantial dose of trivalent arsenic that was likely
responsible for his death, making the case for poisoning
stronger, although exactly who administered the poison will
likely remain a mystery.193
4.3. Iatrogenic Toxic Metals
In rare cases, harmful effects from heavy metal ion intoxication
have resulted from medical treatment, which is known as
iatrogenic, or physician induced, exposure. We note in passing
that mercury exposure from dental amalgam, considered in
section 4.1, constitutes a potential iatrogenic exposure to a toxic
metal, although the negative consequences of this are still a
matter of debate, so this may not be the best example. One
example in which XFI has provided definitive information is
that of the gadolinium contrast agents. Trivalent gadolinium
magnetic resonance imaging contrast agents have many
excellent properties, including enhancing water T1 relaxation
through interaction with the strongly paramagnetic Gd(III).194
These Gd(III) agents are clinically presented in the form of
chelation complexes, and are in general very well tolerated with
only a very low incidence of anaphylaxis.195 Indeed, they are
considered better tolerated than the very commonly used
iodinated X-ray CT contrast agents.195 The Gd drugs are
typically eliminated in the urine with a half-life of only 80 min
in healthy patients.196 However, in patients with kidney
insufficiency, elimination is prolonged and with chronic renal
failure can be between 30 and 130 h.196 In such patients,
repeated administration of Gd contrast agents may trigger
nephrogenic systemic fibrosis (NSF).197 NSF is a very serious
syndrome characterized by red skin areas or plaques that
successively develop to painful thickened skin with a wood-like
texture developing over several weeks. The fibrosis may occur
many months after the use of the contrast agent and typically
starts at the extremities, may spread to the trunk, and may also
progressively affect skin, joints, eyes, and internal organs.198,199
XFI has been used to definitively identify Gd deposition within
biopsied tissue samples from NSF patients.200,201 Moreover,
George et al. have determined that the deposited Gd was no
longer bound to the original contrast agent chelator, and was
instead within a Na-, P-, and Ca-rich region,201 which was
spectroscopically consistent with a GdPO4-type chemical
form.200,201 NSF is thus thought to be associated with release
of Gd(III) from the chelator, and recommendations as to
choice of contrast agent are now in place based on perceived in
vivo stability of the various chelators. Optimization of a high-
affinity Gd(III)-specific chelator using criteria similar to those
developed for other metals202,203 might prove useful in this
area.
4.4. Neurodegenerative Diseases
Recent advances in understanding the role of trace metals in
neurodegerative diseases have been gained through the
application of XFI. A good general overview of XFI in
neurodegenerative diseases has recently been provided by
Bourassa and Miller,204 and the potential of XFI has been
eloquently discussed by Popescu, Nichol, and co-workers.205,206
There remains much groundwork to be done in this area,
including determination of elemental distributions, concen-
trations, and chemical species within cultured neurological cells
and from ex vivo tissues. Examples of the type of groundwork
being carried out come from Ortega and Carmona et al.,207,208
who have mapped the elemental distribution in dopaminergic
cells and neuritic processes at high spatial resolution (90
nm).207,208 Their results have identified iron-rich structures
collocated with neurovesicles,207 as well as elevated Cu, Zn, and
Pb within neuritic processes, which, excluding the latter, may be
intrinsic components related to the protein machinery involved
in these outgrowths.
The infectious miss-folded form of the prion protein is well-
known as the cause of fatal neurodegenerative prion diseases,209
including Creutzfeldt−Jakob disease in humans and bovine
spongiform encephalopathy, commonly known as “mad cow
disease” in cattle. The normal function of the properly folded
nonpathogenic form of the prion protein has been the focus of
debate. Prion protein is highly expressed in the brain and
central nervous system and has been proposed to have a role, at
least in part, in regulating trace metals.210 Pushie and co-
workers have used XFI to map the trace metal distribution in
the brains of transgenic mice expressing different levels of the
prion protein, comparing a prion knockout strain, wild-type,
and a prion overexpressing strain.211 The levels of iron, copper,
and zinc were all found to be altered upon changing prion
expression level, although their overall localization within the
brain was not altered. Pushie et al. also used immunohis-
tochemical staining in combination with XFI to reveal that
regions of the brain showing pronounced differences in prion
expression mirrored relative changes in metal levels, although
the changes in metal ion levels were more pronounced and
widespread than the differences in detectable prion expression
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alone.211 In particular, XFI indicated dramatically elevated
copper levels in periventricular regions.211 The extent to which
metal ions play a role in the development and pathology of
neurodegenerative prion diseases is at present unknown;
however, the XFI results clearly indicate a role for prion
protein in the regulation of specific metals within the central
nervous system. This in turn raises the possibility that prion
levels might modulate the progression of diseases in which
altered metal homeostasis is thought to play a pathogenic role
such as Alzheimer’s, Parkinson’s, and Wilson’s diseases, and
disorders such as hemochromatosis.
Parkinson’s disease (PD) is characterized by the loss of
dopaminergic neurons from the substantia nigra. Popescu et
al.13 have used XFI to characterize the iron accumulation
associated with PD in post mortem autopsy sections from
human brain, confirming earlier investigations by alternate
methods such as magnetic resonance imaging. Indeed, the
major point of this work was to present rapid scan XFI as a new
method for investigation of neurodegenerative disease, as the
findings were essentially confirmatory in nature, although they
were at rather higher spatial resolution than previous work.
High-resolution XFI has recently been reported for small
regions of PD brain, targeting specific brain regions that are
known to be vulnerable.212 This work compared the surviving
neurons in normal and PD brains from the substantia nigra and
locus coeruleus, and employed both XFI and conventional
methods to show that both copper and copper transporter
protein 1 were substantially reduced in PD, but that copper-
containing superoxide dismutase was not.212
Alzheimer’s disease (AD) is associated with the formation of
plaques that are known to accumulate trace metals; however,
some animal models of disease have shown significant
differences in the levels of detectable metals accumulated.
The ability of XFI to directly measure the total trace metal
content associated with plaques can clarify ambiguities that may
arise through alternative metal detection methods, such as the
use of metal-specific fluorescent probes. Miller and colleagues
have pioneered synchrotron-based imaging investigations of
AD tissue, using a combination of Fourier transform infrared
(FTIR) and XFI.213 Their XFI results have confirmed the
colocalization of elevated levels of Fe, Cu, and Zn within
human plaques associated with AD214 and have also identified
significant differences in the extent of metal accumulation
between several mouse lines used in AD research.215 Other
examples of the use of XFI include investigation of Zn
distribution in the hippocampus in relation to memory loss and
delayed neurodegeneration associated with stroke,216 epi-
lepsy,217−220 and mechanical brain injury.221
4.5. Pharmacological Applications
The ability to characterize elemental distributions and chemical
forms under conditions of dyshomeostasis as well as to track
the uptake of drug and probe molecules is particularly attractive
in cancer research. Typical approaches use metal-labeled drugs
or other tagged molecules that are anticipated to be
preferentially taken up by the cancerous cells, often by dint
of some facet related to the cancerous cell’s growth or nutrient
requirements; the targeted location within the tumor or tumor
cells can be identified through tracking the tagging element.222
XFI has been used to identify the localization of Gd and Pt
within treated tumor cells,223 where incorporation of these
heavy elements is ultimately anticipated to enhance neutron
capture therapy and synchrotron stereotactic radiotherapy
treatments. XFI tomography has been used to map the
platinum distribution in DLD-1 colorectal cancer cell spheroids
that had been exposed to platinum-containing anticancer
drugs.224,225 This work showed for the first time that the
anticancer agent can accumulate in the central hypoxic and
necrotic region of the tumor spheroids, and that the charge on
the complex can affect cellular uptake and modulate tumor
penetration.224 Two Ru(III)-based drugs, NAMI-A and
KP1019, are structurally similar but possess vastly different
anticancer properties. NAMI-A has been shown to inhibit
metastasis formation,226 whereas KP1019 shows efficacy in
inducing apoptosis in primary tumors.227 Aitken et al.228 have
investigated the cellular fate of both Ru-based drugs via intact
single cell XFI and found that uptake of KP1019 appears to
disrupt Fe metabolism. The KP1019-treated cells showed
ruthenium apparently localized to the nucleus, which was
consistent with its wide range of applicability against primary
tumors, whereas NAMI-A did not show any significant Ru
uptake into cells, consistent with its proposed extracellular level
of action.228 Ruthenium anticancer drugs usually contain N-
heterocyclic ligands to Ru, such as the bis-indazole coordination
in the case of the drug KP1019, in which the two heterocycles
bind axially with the pseudo-octahedral coordination being
completed by four equatorial chloride ligands. One important
question has been whether the Ru remains coordinated to the
N-heterocycle in the cell. Recent XAS data229 clearly indicate
that substantial chemical modification rapidly occurs in
biological media, but these measurements are most sensitive
to the loss of coordinating chloride and sulfur donors, so
whether the heterocycle remains coordinated to the metal was
not clear. This problem has recently been addressed in novel
experiments using iodinated analogues of ruthenium anticancer
drugs.230 By quantitative monitoring of both the ruthenium and
the iodine X-ray fluorescence, colocalization of the two
elements was clearly demonstrated,230 indicating that the
Ru−N bonds likely remain intact. These results are expected
to be important in future refinements of these promising
anticancer drugs.
The selenium-containing drug ebselen [2-phenyl-1,2-benzo-
selenazol-3-one] is an antioxidant drug, which shows
considerable promise in the treatment of stroke, with
demonstrated reduced infarct volumes in focal ischemia.231
Ebselen has been postulated as an in situ mimic of glutathione
peroxidase.232 XFI has been applied to ebselen-treated rodent
neuroblastoma cells to develop an understanding of the
mechanism of action of this novel drug.233 Selenium was
localized in a specific region of the cell, which, through
comparison with phosphorus and potassium localizations, was
postulated to correspond to the cellular endoplasmic
reticulum.233 Most notably, an ebselen-induced efflux of
potassium, chloride, and calcium was observed in this study,
changes that are characteristic of the induction of oxidative
stress. Thus, almost paradoxically, the antioxidant effects of
ebselen may not be a direct consequence of any antioxidant
abilities of the drug itself, but rather may be due to induction of
cellular antioxidant defense mechanisms through induction of
an oxidative stress response.233
XFI has also been used to develop an understanding of the
mechanism of action of some novel antibiotics to combat
pathogenic Escherichia coli. The majority of urinary tract
infections (UTI) are caused by what are known as
uropathogenic E. coli.234 Orally administered gallium maltolate
has been used to successfully treat UTI mice infected with a
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uropathogenic strain of E. coli. XFI showed that Ga was
localized in the transitional epithelium of the bladder, which is a
potential site of E. coli.235 These results indicate that Ga
compounds may prove to be effective in antimicrobial therapy
for UTI caused by uropathogenic E. coli.
As a final topic in this section, we turn to arsenical-based
chemotherapy. Arsenic is best known as a poison, as we have
discussed in section 4.2. Legitimate use of arsenic compounds
as drugs has been extant since the advent of salvarsan in
1909.236,237 In more recent years, arsenic trioxide has become
established as a highly effective treatment for acute
promyelocytic leukemia, and at the time of writing there are
over 100 clinical trials of arsenic compounds registered with the
United States Food and Drug Administration.238 As discussed
above, Munro et al. have used XFI to show that arsenite-treated
human hepatoma cells present arsenic localization in the
nucleus,184 and these workers have also used a combination of
XAS and XFI to show that [CH3As(GS)2] and [(CH3)2As-
(GS)] (where GS is glutathione bound through its cysteine
thiolate) were produced in the cells.239 There remains much
uncertainty concerning the mechanism of action of arsenic
drugs in chemotherapy,238 and, given the sensitivity of arsenic
XAS as a spectroscopic probe,173 it seems very likely that
applications of XFI will play an important role in understanding
the mechanism of action of existing drugs, and in the
development of new and more effective agents.
4.6. Selenium Biochemistry
Synchrotron XFI and spectroscopy has also been used to
redefine our understanding of cellular selenium biochemistry, in
part through characterization of subcellular selenium local-
ization and speciation.240,241 A long-held belief has been that
subcellular HSe− comprises the intracellular Se store; however,
no evidence for this chemical form of Se has been found in
human lung cancer A549 cells.242 A novel finding using the
same cell system was that selenite treatment induced localized
selenium deposits within cells, and that these were associated
with an approximately 2-fold increase in colocalized copper.243
Despite the colocalization, no evidence was found for chemical
bonding between the two elements.243 Bulk selenium EXAFS
indicated the presence of Se−S and Se−Se backscattering, and
μ-XAS of the highly localized selenium regions was mostly
elemental selenium. Weekley et al. point out that the selenium
levels were some 13-fold higher than the observed Cu levels, so
that Se−Cu might not be observable in the presence of
significant other types of bonding. Weekley et al.243 were not
able to examine the Cu μ-XAS, so that while there is no
evidence for it, a chemical association between the two
elements cannot yet be ruled out. Weekley et al. also suggest
that the copper accumulation might be a response to the
toxicity of the selenium,243 although at the time of writing more
research is required to elucidate the molecular basis of this
colocalization. Weekley et al. have recently extended these cell
culture studies with similar experiments on kidney tissues from
rats given selenite supplements.244 In these tissues, a selenium
and copper colocalization was observed, and the bulk of the
selenium was found to be in species containing Se−Se bonding
and no evidence for Cu−Se species was found, just as with the
previous cell culture experiments,243 where Cu was predom-
inantly bound to sulfur and nitrogen. Moreover, the expression
levels of superoxide dismutase 1 did not change, so
upregulation of this enzyme has no role in the observed
copper accumulation.244 Selenium accumulation has been
reported in neuromelanin deposits in the substantia nigra of
human brain.245 In this study, XFI indicated iron-rich
microdeposits associated with pigmented neuromelanin, with
colocalized sulfur, calcium, manganese, copper, zinc, and
selenium.245 Bohic et al. suggest that the increased selenium
is likely to be associated with glutathione peroxidase.245 The
results are interpreted in the context of neurological develop-
ment, and, interestingly, these workers observe changes in
elemental composition and in the sulfur XAS spectra of
neuromelanin deposits with the age of the individual from
which the brain sample was taken.245 However, post-mortem
chemical changes associated with sample preparation (formalin
and paraffin embedding) might distort the sulfur biochemistry
(section 2.12).
XFI has been used to investigate the roles of selenium in
spermatogenesis with a dramatic increase in selenium in late
spermatids, with selenium concentrating at the luminal side of
elongating spermatids.246 XFI of knockout mice lacking
mitochondrial glutathione peroxidase 4 and lacking selenopro-
tein P showed no elevated selenium levels.246 Thus, selenium
transport was found to be associated with selenoprotein P, and
accumulation with mitochondrial glutathione peroxidase 4.246
In the spermatozoa, selenium was found to be colocalized with
copper and iron, and primarily located in the mitochondria-rich
sperm midpiece. These workers also estimated concentrations
of selenium in the sperm cell head and the sperm cell midpiece
to be 29 and 377 μM, respectively.246 These levels are
considerably above what are normally considered as toxic levels
of selenium, illustrating the ability of the sperm cells to handle
these high levels.246
4.7. Pathological Organisms
New insight into the nutrient requirements of the erythrocyte
pathogen, Plasmodium falciparum, associated with malaria, has
been gained through elemental mapping of red blood cells
during P. falciparum infection and may point to new
biochemical avenues to combat malaria. Using a combination
of XFI and ICP-MS, Marvin et al.247 have identified that the P.
falciparum parasite induces massive Zn accumulation within the
host erythrocyte.247 Zinc accumulation occurs late in the
pathogen’s lifecycle, associated with replication of mitochon-
dria. The accumulated Zn was integral for propagation of the P.
falciparum pathogen, as depletion of free Zn through
administration of a strong Zn2+ chelator halted parasite growth.
Significant areas of growth are in cellular and subcellular
imaging. These areas will be particularly useful for identifying
target organs and cellular fates of trace element containing
drugs or probe molecules (i.e., cancer or tagged metabolites).
For the foreseeable future, these experiments will be of benefit
to informing better drug or target molecule design as well as
improving treatments, while the high radiation doses, on the
other hand, generally preclude large-scale experiments on live
subjects. Using XFI imaging to identify changes in localization,
concentration, and chemical speciation is readily obtainable, but
a critical challenge for this field is extending the wealth of
insight and information to the underlying biochemical
processes and metabolic pathways from which they arise. As
the field matures, additional methods will need to be integrated
to provide the kinds of insight necessary for understanding the
significance of XFI imaging data. One such example is the
application of peripheral techniques to tissue or biological
matrix XFI imaging, such as imaging of electrophoresis gels,
where components can be separated and their trace element
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composition determined.248−250 These data can then be related
back to elemental or chemical speciation maps to aid in
identification and characterization.
5. SYNERGY WITH OTHER METHODS
A number of other methods can provide information that is
complementary to that available from XFI and vice versa. In
this section, we will discuss these techniques with an emphasis
on the information provided by XFI, and upon overlap and
complementary information.
5.1. Magnetic Resonance Imaging
Magnetic resonance imaging (MRI) is a widely used and very
successful clinical and research imaging technique. It has the
significant advantage over XFI of being noninvasive and
available for large samples, such as intact humans, with
moderate spatial resolution. Metal ions can be detected by
MRI but are sensed only indirectly and only when in
paramagnetic oxidation states through their influence on
water proton relaxation times. Hopp et al.251 and Zheng et
al.252 have used XFI to calibrate the iron levels in MRI using
susceptibility weighted imaging at 1.5 T and susceptibility
mapping at 3 T, respectively. Susceptibility mapping estimates
of iron correlate well with those determined by XFI251,252 in
both cadaver brain and ferritin phantoms. This calibration
provides an excellent example of translational research with
direct impacts relevant to methods for diagnosis of human
diseases.
5.2. Mass Spectrometry Imaging
Mass spectrometry imaging (MSI) is an increasingly used
family of techniques that are capable of mapping both metals
and biomolecules. Laser-ablation inductively coupled-plasma
mass spectrometry (LA-ICP-MS) uses a laser beam focused to
micrometer size on a sample to ablate small particles from the
surface of the sample. These are then fed to an inductively
coupled plasma (ICP) source, which vaporizes, atomizes, and
ionizes the ablated particle. The ICP source in turn feeds a
mass spectrometer, and the ions are separated and detected
according to their mass to charge ratio m/z. LA-ICP-MS can
provide elemental maps with resolution and sensitivity similar
to that of XFI,253 but with better access to the lighter elements
such as carbon.254 The ideal sample thickness for LA-ICP-MS is
20−30 μm,253 and well-defined methods for quantification have
been established.254,255 In general, data collection times for LA-
ICP-MS are rather longer than for XFI; for example, data
acquisition of a whole transverse section of rat brain with LA-
ICP-MS at a resolution of 120 μm will take 3−4 h, whereas the
same resolution XFI scan might take less than 1 h. However,
the LA-ICP-MS experiment has the significant advantage that
commercial instruments are available and access to large
specialized XFI synchrotron infrastructure is not needed.
Whereas LA-ICP-MS can provide elemental mapping informa-
tion essentially similar to that of XFI, other mass spectrometry
methods can provide quite different and highly complementary
information. Matrix-assisted laser desorption ionization
(MALDI) mass spectrometry can spatially resolve molecular
weights in the range of m/z ∼1000 to ∼200 000, and, in some
cases, higher.256 Tissue section thicknesses of ∼10 μm are
compatible with XFI, but electrically conductive sample plates
are required, which may not be directly compatible with XFI.
MALDI MSI also requires deposition of a compatible matrix
material to aid desorption of molecules from the surface of the
sample. Matrix deposition is critical for reproducibility and
spatial resolution, although smaller matrix droplets reduce the
detectable signal as there are fewer ions generated. Prior to
matrix deposition, MSI sample preparation often includes
several rinsing steps, which may include ethanol and acetic acid
to improve the quality of the MS data. In our experience,
rinsing tissue sections with deionized water can remove labile
pools of some elements, although their originally associated
proteins may persist. While these changes in elemental content
may be detectable with XFI, they are unlikely to be
consequential to MSI as they likely represent the loss of low
molecular weight species or the loss of labile ions from sites
within their parent protein, which may still persist after rinsing.
Spatial resolution in MALDI MSI can approach 10 μm,
although careful consideration must be given to the method of
matrix deposition, as well as the acquisition method, to ensure
resulting images contain spatially relevant information at these
length scales. There are also relatively fewer molecules available
for desorption below 10 μm, which significantly limits
detectability. Oversampling methods, where the step size of
the sample position motor is smaller than the laser spot size,
have been successfully applied257 in a manner analogous to that
of XFI. However, unlike XFI, there is less material available for
ablation and for subsequent detection from the surface in
subsequent steps after the initial spot. A microscope mode
method of MALDI MSI has also been developed, whereby
snapshots of a large area of sample are collected and mapped to
a position sensitive detector, affording significantly improved
spatial resolution equivalent to ∼4 μm.258
MSI requires generating ionizable species that can be readily
ablated from the sample surface; however, some biomolecular
species may not be amenable to such methods. Further
challenges are posed by the ion-suppression effect, the possible
presence of isobaric species, as well as detection of low
molecular weight species. Separation of isobaric species is
possible with ion mobility mass spectrometry,259 whereby ions
are separated according to their collision cross section as well as
their mass-to-charge ratio, making analysis of complex mixtures
readily accessible, as well as separation of low molecular weight
species. Alternate methods of detection for low molecular
weight species, such as drugs or probe molecules, can
potentially be overcome by subsequent collision-induced
dissociation of the molecular ion peak belonging to the
suspected parent species, followed by confirmation of the
parent ion from its characteristic molecular fragments.
Combining molecular imaging techniques, such as MSI, with
the additional wealth of data afforded by XFI as well as XAS
characterization of chemical species within particular regions of
interest is particularly attractive and holds promise for more
complete characterization of molecular species within biological
tissues at the cellular (and in some cases subcellular) level.
Mass spectrometric analysis consumes sample material,
requiring that MSI be performed on the same sample following
imaging and analysis with nondestructive methods such as XFI,
or be performed on adjacent sample sections.
5.3. Fluorescent Molecular Probes
Metal ion fluorescent probes are small molecules that are
specifically synthesized to bind metal ions with a degree of
selectivity, and, upon binding, to change their optical
fluorescent properties.260 There are significant advantages to
this approach, including the convenience of optical microscopy,
and the short time required to acquire an image. To illustrate
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the relative strengths and limitations, we will discuss three
different examples: mercury, copper, and zinc.
5.3.1. Mercury. As we have already discussed XFI
applications to mercury toxicology in some detail (section
4.1), as an example we will examine the comparative strengths
and limitations of mercury fluorescent probes. This area has
recently been reviewed by Nolan and Lippard;261 the reader is
referred to this work for a comprehensive discussion. Mercury
sensors can be categorized into molecules that either turn on or
turn off fluorescence upon mercury exposure,262,263 including
novel approaches in which mercury causes chemical mod-
ification of the sensor.264−266 The primary concerns with these
approaches are the chemical modifications of the mercury, the
specificity of the probe, and sensitivity. The turn-on probes
developed by Chang and co-workers have excellent reported
specificity, but because the in vivo levels of Hg2+ can be several
orders of magnitude lower than other species such as Zn2+,
despite the response of the probes for Hg2+ being many times
that of other cations, some confusion may be possible.
Chemical modification of the endogenous mercury that is
inherent in these methods may also be a cause for concern.
Thus, XFI of both mercury and methylmercury compounds has
clearly shown that uptake, transport, and localization all
depended heavily upon the chemical form in which mercury
is presented,51 and in vivo association with a sensor molecule
might change the metal distribution. Insofar as sensitivity is
concerned, both XFI and fluorescent probes give sufficient
response to estimate mercury in tissue samples, although the
sensitivity of XFI depends strongly upon the source of X-rays
and detector technology being employed.
5.3.2. Copper. Studies using copper fluorescent probes
side-by-side with XFI have been reported. Price et al.267 have
studied the Cu(I)-specific fluorescent probe CS1.268 Price et al.
found that CS1 competed poorly with endogenous copper
handling biomolecules, and that increased fluorescence from
CS1 was difficult to directly attribute to coordination of the
probe’s target, Cu(I).267 Their results also highlight important
caveats in the use of fluorescent probes, which might not be
evident without complementary XFI characterization; in their
case, trafficking of CS1 to lysosomes, and its localization
therein, could have ultimately altered some of the subcellular
distribution of Cu(I), which was significantly different in
controls as compared to the same compartment in treatments
where the fluorescent chelator was employed. Thus, when
compared to the use of fluorescent probes, XFI has the
significant advantage that chemical treatments or chemical
modification of the target metal is not required. Fluorescent
probes may also specifically target a labile pool of the metal ion
of interest, or those occurrences of the metal ion in which it
may be competitively exchanged. In such cases, while the use of
fluorescent probes alone might be misleading, the combined
use of XFI and fluorescent probes can in principle provide
highly complementary information, with XFI probing total
metal and the sensor molecules only labile metals. The benefits
of using both methods have been discussed by Yang et al.,269
who used a combination of XFI in parallel with a different
Cu(I)-specific fluorescent probe CTAP-1, in addition to μ-XAS
to probe chemical form. In this case, the XFI and CTAP-1
images showed similarities, and Yang et al. reported evidence
for a kinetically labile copper pool, predominantly localized in
mitochondria and Golgi.269
5.3.3. Zinc. As the second most abundant transition metal
in the mammalian body, zinc plays many crucial roles in
biological chemistry. Although the metal itself is incapable of
redox chemistry under physiological conditions, depleted or
elevated zinc levels are known to indirectly affect cell redox
status, with carefully balanced zinc homeostasis being crucial for
cellular viability. In addition, redox stability of Zn2+ is a likely
reason underlying many of the biological functions of the metal,
particularly redox independent cell signaling pathways. For
these reasons, imaging the distribution and alterations in local
concentration of zinc is of great interest. However, studies in
this field may be problematic, particularly in the field of
neuroscience, due to the occurrence of several Zn2+ pools
having significant chemical differences. Specifically, although
the majority of zinc is tightly bound within proteins, a sizable
percentage of brain zinc exists as a loosely bound or
“chelatable” pool of zinc, particularly in the hippocampus.
This “chelatable” zinc has long been thought to play crucial
roles in neuronal signaling pathways, although the complete
role of this zinc pool remains to be elucidated.270,271
“Chelatable” zinc has previously been imaged using cytochem-
ical methods (Timm’s staining),272 and, more recently, a wide
range of zinc chelating fluorophores have been designed to
study the chelatable zinc pool.273,274 As reviewed recently,
however, nonspecific binding of Zn2+ chelators to other
divalent ions (i.e., Ca2+), or to protein bound Zn2+, has the
potential to confound studies of the chelatable Zn
pool.273,275−277 Therefore, a combined approach with XFI to
determine the distribution of total zinc, in combination with
fluorescence probes and/or cyto-chemistry to study chelatable
zinc, has been valuable. In an elegant example of this approach,
traditional biochemical methods were used to demonstrate the
location of the ZnT3 protein and chelatable zinc pool in wild-
type and in ZnT3 knockout mice.278,279 XFI was then used to
demonstrate that the decrease in chelatable zinc was not due to
altered speciation or coordination of zinc, but due to a net
decrease in total zinc in ZnT3 knockout mice.280 This
important contribution conclusively demonstrated a direct
role of ZnT3 as a Zn transport protein.280
Overall, it is clear that a combination of techniques provides
strong mutual benefits for understanding and characterizing
trace metals in biological systems. Thus, XFI and μ-XAS can
probe total elemental distributions and provide chemical
speciation information, while prudently chosen fluorescent
probes can be used to target and identify labile or localized
pools of the target metal.
5.4. Fourier Transform Infrared
Fourier transform infrared (FTIR) spectroscopy provides a
wealth of molecular information for biological samples, is
nondestructive, and can be performed on the same sample as
XFI analyses if a suitable substrate is used.
The FTIR spectrum results from the absorption of
characteristic wavelengths of light that correspond to the
frequency of an oscillating molecular dipole. FTIR spectro-
scopic maps or images are best viewed as “functional group”
maps or images, in which a variety of organic functional groups
present in lipids, proteins, carbohydrates, and various
metabolites can be distinguished. Detailed reviews of FTIR
data acquisition methods have recently been reported,281−283
and we present only a brief discussion here. Collection of FTIR
spectroscopic data may be performed in two different modes,
each with specific advantages. FTIR mapping mode works in a
way similar to many XFI experiments (e.g., see section 2.4); a
small beam, typically defined with an aperture, is employed, and
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the sample is moved in a step-by-step manner to spectroscopi-
cally map an area. The second approach, known as FTIR
imaging, does not use an aperture, but incorporates wide-field
sample illumination and detection using a focal plane array
detector to quickly acquire FTIR images of substantial areas of
the sample. In general, the point-by-point mapping approach
provides superior quality spectra over a larger range than can be
achieved with the imaging approach, but the focal plane array
detector allows substantial oversampling (e.g., pixel sizes <1
μm) relatively rapidly, so that images can be acquired in several
minutes instead of hours or days for point-by-point mapping.284
With both methods, synchrotron light is needed to provide
sufficient spectral brightness for diffraction-limited spatial
resolution, although globar sources and benchtop instruments
are well suited to imaging larger samples at spatial resolutions
of approximately double the diffraction limit, making them a
competitive alternative to synchrotron-based FTIR imaging for
some samples.
The diffraction-limited spatial resolution of FTIR images is
2−10 μm, which is comparable to most XFI experiments.
Moreover, the sample substrates, sample thicknesses, and
methods of sample preparation can be similar for both
methods. For example, cells grown on infrared-transparent
Si3N4 membranes, or on thin carbon-polymer-based films (e.g.,
mylar), can be investigated with FTIR imaging as air-dried,
freeze-dried, or chemically fixed samples, and the same cells can
then be analyzed with XFI. Likewise, sections from hard tissues
such as bone or teeth, or from soft tissues such as brain or
tumors, can be mounted on Si3N4 or polymer films and
analyzed in transmission geometry by FTIR, or mounted on
aluminum or gold-coated slides and analyzed in transflection
geometry with FTIR, prior to XFI. Transflection measurements
use a reflective substrate and measure transmission spectra from
the two passes through the sample, the first through sample to
the reflective layer, and the second on the return out of the
sample, with a very small reflection contribution from the
surface of the sample itself. We note that, as discussed by
Bassan et al.,285 artifacts can occur when biological samples are
analyzed in transflection geometry so that such analysis should
done with care. In many cases, examination of exactly the same
sample by FTIR and XFI is not needed as serial sections of a
sample are often available, so that alternate sections can be
mounted on CaF2 or BaF2 for FTIR and on plastic or Si3N4
films for XFI.
One of the major applications of complementary FTIR and
XFI analyses has been the field of neuroscience. This approach
is well suited to study spatially resolved cause and effect
relationships between molecular alterations such as protein
misfolding and the formation of β-sheet aggregates and metal
(Fe, Cu, Zn) and ionic (Cl−, K+, Ca2+) homeostasis. Miller and
co-workers have successfully applied a combined approach to
study both metal content and protein secondary structure
within amyloid plaques in Alzheimer’s disease,286 metal content
and protein secondary structure within individual neuons in
Parkinson’s Disease and Amyotrophic lateral sclerosis,287 and
protein aggregation and elemental content in the hippocampus
after “epileptic”-like seizures.288,289 Additional examples include
the use of FTIR spectroscopic imaging to identify crystalline
creatine deposits in diseased brain tissue, and corresponding
elemental analysis of these deposits using XFI.290
In addition to analysis of brain tissue, a combined FTIR and
XFI approach has been used to monitor the molecular and
elemental changes induced in tumor spheroids by chemo-
therapeutic drugs.291 Likewise, the use of FTIR in combination
with XFI and XAS to study molecular alterations induced by
metal drug uptake in cancer cells has been reviewed recently.292
A significant advantage of this combined multimodal approach
is that greater insight is obtained regarding chemical alterations
induced in cells at the site of drug uptake/localization, and
molecular alterations that result as secondary consequences,
which are not colocalized with administered drugs. Other
samples that have been successfully investigated at the
subcellular level using a combined FTIR and XFI approach
have previously been reviewed,293 and include cultured
adipocytes and cardiomyoctes.105
5.5. Novel X-ray Imaging Methods
A number of new and novel imaging modalities of a
complementary nature have recently been reported. For the
stable iron isotope 57Fe (2% natural abundance), nuclear
resonance is readily excited by synchrotron light at 14 412 eV,
and imaging with both coherent and incoherent nuclear
resonant scattering has recently been explored at a spatial
resolution of 5 μm.294 The coherent nuclear resonant scattering
is more commonly known as synchrotron Mössbauer spec-
troscopy (SMS);295 it is measured in the forward direction (i.e.,
in the direction of the beam), and yields information on the
magnetic properties of the iron in the sample. The incoherent
nuclear resonant scattering is measured at 90° to the incident
beam, is probably less useful than SMS imaging in a biological
context, and yields information on lattice dynamics. While pilot
SMS imaging studies have explored only very high concen-
trations, biological systems are likely to become possible with
new chopper technology. The major disadvantage of SMS
imaging is that, for all practical purposes, it cannot be used for
elements other than iron. However, given the widespread
importance of iron in biology, the technique is still likely to be
important in future studies.
Another method of potential importance that to date has
remained unexplored in an imaging modality is high-resolution
fluorescence spectroscopy.296,297 Typically, these data are
collected using a Johann geometry bent-crystal analyzer
apparatus, often constructed as an array to increase the solid
angle. Here, minor fluorescence lines, such as the Kβ″, which
shift depending upon chemical environment, can be monitored.
The major disadvantage with this method is low sensitivity as
the aforementioned minor fluorescence lines are at best
hundreds of times less intense than Kα1 and Kα2 lines, and it
is possible that this may never become practical on the most
challenging biological samples. Although they are not strictly
speaking X-ray fluorescence spectroscopy, resonant inelastic X-
ray scattering298 and X-ray Raman299 experiments are
conducted with essentially the same bent-crystal analyzers as
high-resolution fluorescence, although a different geometrical
arrangement of crystals may be used for the different
experiments. All of these are inherently low sensitivity methods,
and very high spectral brightness X-ray sources are required for
them to be viable. Despite caution about the practicability of
these methods for many biological systems, the authors are
aware of at least three such bent-crystal analyzers that are, or
will be, available on XFI compatible beamlines, and it seems
likely that this area will be explored in future applications.
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6. CONCLUDING REMARKS: REFINEMENTS AND
FUTURE DIRECTIONS
Future applications of XFI will require an increase in the
capabilities of beamlines, scanning systems, and detectors. The
capabilities of synchrotron radiation sources to provide
improved spectral brightness continue to advance. Modern
synchrotron light sources are also considerably more stable
than in previous years, and are also able to operate essentially
continuously, in what is called top-up mode, without routine
interruptions in beam delivery to refill the electron storage ring.
As the sources improve, the technique of XFI will undoubtedly
improve to keep pace. Faster and more efficient detector
systems with good energy resolution, together with faster
readout electronics, will be increasingly important. Also
important will be improved speed of data acquisition and
sample scanning systems. As we have discussed, biological
samples are inherently delicate, and improved cryogenic
protection for larger samples is likely to be important. The
multienergy methods discussed in section 2.6 may also improve
to the ideal of collecting a complete μ-XAS spectrum for every
pixel within a tractable amount of time, and as throughput and
data acquisition improve then so will analytical methods and
automation. The ability to change spatial resolution on a
sample will also likely be an important future capability. At
present, if an experimenter wishes to use XFI to interrogate a
region of interest within a sample at substantially higher
resolution, it may require a different beamline and sometimes
even necessitate relocating to a different synchrotron light
source. The advantages of being able to dynamically change
spatial resolutions on one experimental station would be
significant. At the time of writing, the authors know of only one
beamline for which this is planned (the BioXAS Imaging
beamline at the Canadian Light Source). Finally, improved
overlap of XFI with other methods and alternate imaging
modalities are likely to continue to see growth and increasing
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ABBREVIATIONS
AD Alzheimer’s disease
ADC analog to digital converter
APS Advanced Photon Source
CLS Canadian Light Source
EXAFS extended X-ray absorption fine structure
FET field-effect transistor
FTIR Fourier transform infrared
fwhm full width at half-maximum
FSI fluorescence subtraction imaging
HWHM half-width at half-maximum
K−B Kirkpatrick−Baez
KES K-edge subtraction
LA-ICP-MS laser-ablation inductively coupled-plasma mass
spectrometry
MALDI matrix-assisted laser desorption ionization
MCA multichannel analyzer
MRI magnetic resonance imaging
MSI mass spectrometry imaging
NSF nephrogenic systemic fibrosis
PET positron emission tomography
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PCA principal component analysis
PD Parkinson’s disease
RSXRF rapid scan X-ray fluorescence
SCA single channel analyzer
SMS synchrotron Mössbauer spectroscopy
SRIXE synchrotron radiation-induced X-ray emission
SSRL Stanford Synchrotron Radiation Lightsource
STXM scanning transmission X-ray microscopy
SVD single value decomposition
SXRF synchrotron X-ray fluorescence
SXFI synchrotron X-ray fluorescence imaging
UTI urinary tract infection
XANES X-ray absorption near-edge fine structure
XAS X-ray absorption spectroscopy
μ-XAS micro X-ray absorption spectroscopy
XFI X-ray fluorescence imaging
XFM X-ray fluorescence mapping
XFM X-ray fluorescence microscopy
XRF X-ray fluorescence
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Strüder, L.; Eckhardt, R.; Hermenau, K.; Schaller, G.; Schopper, F.;
Jaritschin, O.; Liebel, A.; Simsek, A.; Fiorini, C.; Longoni, A. Nucl.
Instrum. Methods Phts. Res., Sect. A 2010, 624, 270.
(37) Funk, T.; Deb, A.; George, S. J.; Wang, H.; Cramer, S. P. Coord.
Chem. Rev. 2005, 249, 3.
(38) Ryan, C. G.; Kirkham, R.; Hough, R. M.; Moorhead, G.;
Siddons, D. P.; de Jonge, M. D.; Paterson, D. J.; De Geronimo, G.;
Howard, D. L.; Cleverley, J. S. Nucl. Instrum. Methods Phys. Res., Sect. A
2010, 619, 37.
(39) Kirkham, R.; Dunn, P. A.; Kuczewski, A. J.; Siddons, D. P.;
Dodanwela, R.; Moorhead, G. F.; Ryan, C. G.; De Geronimo, G.;
Beuttenmuller, R.; Pinelli, D.; Pfeffer, M.; Davey, P.; Jensen, M.;
Paterson, D. J.; de Jonge, M. D.; Howard, D. L.; Küsel, M.; McKinlay,
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